

“Œ“ú–{‘å�k�Ћً}ƒtƒH�[ƒ‰ƒ€
5ŒŽ20“ú�i‹à�j 15:15�`17:00�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ‘c•ƒ�]�@Œ³�i‘æ52‰ñ“ú–{�_ŒoŠw‰ïŠw�p‘å‰ï�@‘å‰ï’·�j
-
- �…àV�@‰p—m�i“ú–{�_ŒoŠw‰ï�@‘ã•\—�Ž–�j
Šî’²�u‰‰
�ЊQ‚ÌŒ»�ê‚©‚ç
-
- �‚‹´�@’q�iŠâŽèˆã‰È‘åŠw�_Œo“à‰È�j
-
- •l“o�@•¶Žõ�i‚͂܂Æ�_Œo“à‰ÈƒNƒŠƒjƒbƒN�j
�ЊQ‚ÌŒ»�ê‚©‚ç
-
- �–Ø�@�³Žu�i“Œ–k‘åŠw�_Œo“à‰È�j
�ЊQ‚ÌŒ»�ê‚©‚ç�iƒCƒ“ƒ^�[ƒlƒbƒg’†Œp�j
-
- ŠâŒ©�@‰�ä�iŠâŒ©�_Œo“à‰Èˆã‰@�j
�ЊQ‚ÌŒ»�ê‚©‚ç
-
- ‰F�ì�@‹`ˆê�i•Ÿ“‡Œ§—§ˆã‰È‘åŠw�_Œo“à‰È�j
�ЊQŽx‰‡�|�s�
-
- ’†“c�@�ŸŒÈ�i�i‘O�jŒú�¶˜J“�ÈŽ¾•a‘Î�ô‰Û�j
Žw’蔌¾
�ЊQŽx‰‡
-
- ŽR‘º�@�C�i•Ÿˆä‘åŠwˆãŠw•”•�‘®•a‰@�_Œo“à‰È�j
�ЊQŽx‰‡
-
- ‰¬–ì�@”üŒbŽq�i–k—¢‘åŠw�_Œo“à‰È�j
‘��‡“¢˜_
ƒtƒ�ƒA‚ðŒð‚¦‚½ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“
ƒy�[ƒWƒgƒbƒv‚Ö↑
‘å‰ï’·�u‰‰
- �_Œo•Ï�«Ž¾Š³‚Ì•ªŽq•W“IŽ¡—Âð–ÚŽw‚µ‚Ä
5ŒŽ18“ú�i�…�j 13:30�`14:30�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ûü‹´�@�º�i–¼ŒÃ‰®‘åŠw–¼—_‹³Žö�^“ŒŠC’†‰›•a‰@–¼—_‰@’·�j
- ‰‰ŽÒ�F
- ‘c•ƒ�]�@Œ³�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
“Á•Ê�u‰‰
- “Á•Ê�u‰‰1
- Past, present, and future of polyglutamine expansion disease
5ŒŽ17“ú�i‰Î�j 16:45�`18:30�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- Š‹Œ´�@–ÎŽ÷�i—鎈ã—ÉȊw‘åŠw•ÛŒ’‰q�¶Šw•”ˆã—ÕŸŽƒŠw‰È�j
- ‰‰ŽÒ�F
- Kenneth H. Fischbeck�iNeurogenetics Branch, NINDS, NIH, USA�j
- “Á•Ê�u‰‰2
- 1•ªŽq‚©‚ç”]‚Ö�F•¡ŽGƒVƒXƒeƒ€‚ð—�‰ð‚·‚é�VŠT”O
5ŒŽ17“ú�i‰Î�j 16:45�`18:30�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- –öàV�@�M•v�i“Œ‹ž�H‰È‘åŠwˆã—Õی’Šw•”�j
- ‰‰ŽÒ�F
- –ö“c�@•q—Y�i‘å�ã‘åŠw‘åŠw‰@�¶–½‹@”\Œ¤‹†‰È�CNICT ”]�î•ñ’Ê�M�C—�Œ¤QBiC�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
ƒI�[ƒvƒjƒ“ƒOƒZƒ~ƒi�[
- ”]‚̉‘Y�«‚Ì�Å‘O�ü�F�_Œo‹@”\‰ñ•œ�EƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‚̋ߖ¢—ˆ‚Ö‚Ì“W–]
5ŒŽ17“ú�i‰Î�j 16:45�`18:30�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- ‰F�ì�@‹`ˆê�i•Ÿ“‡Œ§—§ˆã‰È‘åŠwˆãŠw•”�_Œo“à‰ÈŠw�j
-
- ”ö“¡�@�°•F�i“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo�¶‰»Šw•ª–ì�j
1�D”]‚Ì’·Šú‰Â‘Y�«‚Ì•ªŽq‹@�\
- ‰‰ŽÒ�F
- ”ö“¡�@�°•F�i“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo�¶‰»Šw•ª–ì�j
2�DŽ¥‹CŽhŒƒ‚É‚æ‚éƒqƒg’†�•�_Œo‚ł̉‘Y�«‚Ì—U“±�FQPS
- ‰‰ŽÒ�F
- ‰F�ì�@‹`ˆê�i•Ÿ“‡Œ§—§ˆã‰È‘åŠwˆãŠw•”�_Œo“à‰ÈŠw�j
3�D”]‘¹��Œã‚Ì‹@”\‰ñ•œ‚Æ”]‚̉‘Y�«�i—Õ�°�j
- ‰‰ŽÒ�F
- •ž•”�@Œ›–¾�i�X”V‹{•a‰@�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Œ¤‹†•”�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
“ú–{�_ŒoŠw‰ï2010”N“x“è—Ñ�ÜŽó�ÜŽÒ�µ‘Ò�u‰‰
5ŒŽ18“ú�i�…�j 13:10�`13:30�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ‘c•ƒ�]�@Œ³�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
-
- �…àV�@‰p—m�i“ú–{�_ŒoŠw‰ï‘ã•\—�Ž–�C“Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@”]�_Œo•a‘ÔŠw•ª–ì�j
ƒp�[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚¯‚é”F’m‹@”\�áŠQ‚ÌŒ¤‹†�F‚Æ‚‚ɎЉï“I”F’m‹@”\�áŠQ‚Æ�G“�‘Ì‹@”\�áŠQ‚Ƃ̊֘A‚ɂ‚¢‚Ä
- ‰‰ŽÒ�F
- ‰Í‘º�@–ž�i�º˜a‘åŠwˆãŠw•”“à‰ÈŠw�u�À�_Œo“à‰ÈŠw•”–å�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
‹³ˆç�u‰‰
- ‹³ˆç�u‰‰1
- –¾“ú‚©‚ç–𗧂ˆã—ÈÀ‘S�F�_Œo“à‰È�f—Âɖ𗧂ƒ�ƒfƒBƒG�[ƒVƒ‡ƒ“ƒ‚ƒfƒ‹
5ŒŽ18“ú�i�…�j 7:45�`8:20�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- �ç—t�@�i�iŽD–yŽR‚Ì�ã•a‰@�j
- ‰‰ŽÒ�F
- ˆÀ“¡�@“N˜N�iˆ¤’mŒ§Œú�¶˜AˆÀ�é�X�¶•a‰@�_Œo“à‰È�j
- ‹³ˆç�u‰‰2
- ‚æ‚‚í‚©‚éˆãŠwŒ¤‹†—Ï—�Žw�j
5ŒŽ18“ú�i�…�j 7:45�`8:20�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- ‹gˆä�@•¶‹Ï�i“ŒŠC‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ”Ñ“‡�@û€•F�i–¼ŒÃ‰®‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�¶–½—Ï—�ˆÏˆõ‰ï�j
- ‹³ˆç�u‰‰3
- –TŽîá‡�«�_Œo�ÇŒóŒQupdate
5ŒŽ18“ú�i�…�j 7:45�`8:20�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- “c’†�@ŒbŽq�i‹à‘òˆã‰È‘åŠw�_Œo“à‰ÈŠw�j
- ‰‰ŽÒ�F
- Œ¢’Ë�@‹M�iŠò•Œ‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo“à‰È�E˜V”NŠw•ª–ì�j
- ‹³ˆç�u‰‰4
- ‘½Œn“�ˆÞ�k�ǂ̕Ï�«‚̂͂¶‚Ü‚è‚Í�_Œo�×–E‚©‚ç‚©ƒOƒŠƒA�×–E‚©‚ç‚©
5ŒŽ18“ú�i�…�j 7:45�`8:20�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- ‰Á“¡�@�M‰î�i’¹Žæ‘åŠwˆãŠw•”•�‘®”]в�«Ž¾Š³Œ¤‹†Ž{�Ý”]�_Œo•a—�•”–å�j
‘½Œn“�ˆÞ�k�Ç�\ƒVƒkƒNƒŒƒCƒ“‚Æ�_Œo�×–E•Ï�«�\
- ‰‰ŽÒ�F
- ‹g“c�@áÁ—��iˆ¤’mˆã‰È‘åŠw‰Á—îˆã‰ÈŠwŒ¤‹†�Š�j
‘½Œn“�ˆÞ�k�ǂ̕Ï�«‚̂͂¶‚Ü‚è‚Í�_Œo�×–E‚©‚ç‚©ƒOƒŠƒA�×–E‚©‚ç‚©�FƒOƒŠƒA�×–E
- ‰‰ŽÒ�F
- ŽR“c�@Œõ‘¥�i�‘—§•a‰@‹@�\‚³‚¢‚ª‚½•a‰@—Õ�°Œ¤‹†•”�j
- ‹³ˆç�u‰‰5
- ‘O“ª‘¤“ª—t•Ï�«�Ç�iFTLD�j‚Ì•ª—Þ‚Æ•a‘Ôupdate
5ŒŽ18“ú�i�…�j 7:45�`8:20�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- ‰ª–{�@�KŽs�iŒQ”n‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”]�_Œo“à‰ÈŠw�j
- ‰‰ŽÒ�F
- ’†–ì�@�¡Ž¡�iީޡˆã‰È‘åŠw“à‰ÈŠw�u�À�_Œo“à‰ÈŠw•”–å�j
- ‹³ˆç�u‰‰6
- –Ɖu—}�§Š³ŽÒ‚É‚¨‚¯‚é�_Œo޾г
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- Œüˆä�@‰hˆê˜Y�i–¼ŒÃ‰®ˆã—ÃZƒ“ƒ^�[�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ŠÝ“c�@�C“ñ�i‚ª‚ñ�EŠ´�õ�ǃZƒ“ƒ^�[“s—§‹î�ž•a‰@”]�_Œo“à‰È�j
- ‹³ˆç�u‰‰7
- �_Œo޾г‚Æ“œ�½�¶•¨Šw�F�V‚½‚È�¶–½�½‚Ì–ðŠ„
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- ‰Á“¡�@�ä•v�iŽRŒ`‘åŠwˆãŠw•”‘æ3“à‰È�j
- ‰‰ŽÒ�F
- •�“¡�@‘½’ØY�i“¡“c•ÛŒ’‰q�¶‘åŠwˆãŠw•””]�_Œo“à‰ÈŠw�j
- ‹³ˆç�u‰‰8
- �ŋ߂̈«�«”]Žîᇎ¡—ÂÌ�i•à
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- �…’J�@’q•F�i“ú–{‘åŠw‘��‡ŠwŒ¤‹†�Š�j
- ‰‰ŽÒ�F
- Žá—Ñ�@�r•F�i–¼ŒÃ‰®‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”]�_ŒoŠO‰ÈŠw�j
- ‹³ˆç�u‰‰9
- ”F’m�Ç‚ÌBPSD‚Ì–ò•¨Ž¡—Ã�F�¸�_‰È‚©‚ç‚̃�ƒbƒZ�[ƒW
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- —L‘º�@Œö—Ç�i‘å�Ÿ•a‰@�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‹´–{�@‰q�iŒF–{‘åŠwˆãŠw•”•�‘®•a‰@�_Œo�¸�_‰È�j
- ‹³ˆç�u‰‰10
- ƒp�[ƒLƒ“ƒ\ƒ“•a‚Ì”F’m‹@”\�áŠQ‚Ì�f•û
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- �¬Ž�@�K�¶�i–¼ŒÃ‰®Žs—§‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‰Í‘º�@–ž�i�º˜a‘åŠwˆãŠw•”“à‰ÈŠw�u�À�_Œo“à‰ÈŠw•”–å�j
- ‹³ˆç�u‰‰11
- ”]�[�Ç�Ä”—\–hupdate
5ŒŽ19“ú�i–Ø�j 7:45�`8:20�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- �r–Ø�@�M•v�i�é‹Êˆã‰È‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- “c’†�@�k‘¾˜Y�i•xŽR‘åŠw•�‘®•a‰@�_Œo“à‰È�j
- ‹³ˆç�u‰‰12
- ”]MRI‚©‚ç•Ï�«Ž¾Š³‚Ì�f’f‚É”—‚é�\•a—��C—Õ�°‚̑Δ䂩‚ç�\
5ŒŽ20“ú�i‹à�j 7:45�`8:20�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- �´�…�@‹P•v�i’鋞‘åŠwˆãŠw•”�_Œo“à‰È�j
- ‰‰ŽÒ�F
- “n•Ó�@�G‹v�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- ‹³ˆç�u‰‰13
- �_Œo“à‰Èˆã‚É•K—v‚Ȉâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒO
5ŒŽ20“ú�i‹à�j 7:45�`8:20�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- Œã“¡�@�‡�i“Œ‹ž‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‹g“c�@–M�L�i�M�B‘åŠwˆãŠw•”�_Œo“ï•aŠw�u�À�j
- ‹³ˆç�u‰‰14
- ‚æ‚‚í‚©‚éCOI �iconflict of interest�j
5ŒŽ20“ú�i‹à�j 7:45�`8:20�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- �²ŒÃ“c�@ŽO˜Y�i“��ªŽR•a‰@�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‘]�ª�@ŽO˜Y�i“ú–{ˆãŠw‰ï—˜‰v‘Š”½ˆÏˆõ‰ï�i“¿“‡‘åŠw‘åŠw‰@ƒwƒ‹ƒXƒoƒCƒIƒTƒCƒGƒ“ƒXŒ¤‹†•”�j�j
- ‹³ˆç�u‰‰15
- Ž©ŒÈ–Ɖu�«�_Œo‹Ø�Ú�‡•”޾г‚Ì•a‘Ô‚ÆŽ¡—Ã
5ŒŽ20“ú�i‹à�j 7:45�`8:20�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- �²‹´�@Œ÷�iˆ¤’mˆã‰È‘åŠw–¼—_‹³Žö�j
- ‰‰ŽÒ�F
- –{‘º�@��Ÿ�i’·�è‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È‘æˆê“à‰È�_Œo“à‰È�j
- ‹³ˆç�u‰‰16
- “�«•Гª’ɂ̑Î�ô‚ÆŽ¡—Ã
5ŒŽ20“ú�i‹à�j 7:45�`8:20�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- ’†“‡�@Œ’“ñ�i’¹Žæ‘åŠwˆãŠw•”ˆãŠw‰È”]�_Œoˆã‰ÈŠw�u�À”]�_Œo“à‰ÈŠw•ª–ì�j
- ‰‰ŽÒ�F
- �´�…�@—˜•F�iŒcœä‹`�m‘åŠwˆãŠw•”�_Œo“à‰È�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
ƒzƒbƒgƒgƒsƒbƒNƒX
- ƒzƒbƒgƒgƒsƒbƒNƒX1�@Neuromyelitis optica�iNMO�j‚Ì‚·‚ׂÄ
5ŒŽ18“ú�i�…�j 8:30�`9:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- Ž…ŽR�@‘×�l�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[•a‰@�j
- ‰‰ŽÒ�F
- “¡Œ´�@ˆê’j�i“Œ–k‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È‘½”�«�d‰»�ÇŽ¡—ÊwŠñ•��u�À�j
- ƒzƒbƒgƒgƒsƒbƒNƒX2�@‘½”�«�d‰»�Ç‚Ì�Å�V‚Ì•a‘Ô‚ÆŽ¡—Ã
5ŒŽ18“ú�i�…�j 9:30�`10:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- �Ö“c�@�F•F�i‹ž“s–¯ˆã˜A’†‰›•a‰@�_Œo“à‰È�j
Pathophysiology of progressive multiple sclerosis: studies in a genetically manipulated murine model
- ‰‰ŽÒ�F
- David Pleasure�iInstitute for Pediatric Regenerative Research and Department of Neurology, UC Davis, USA�j
‘½”�«�d‰»�Ç‚Æ�Á‰»ŠÇ–Ɖu
- ‰‰ŽÒ�F
- ŽR‘º�@—²�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�Š–Æ‰uŒ¤‹†•”�j
- ƒzƒbƒgƒgƒsƒbƒNƒX3�@�_Œo“à‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“�G‚Ä‚ñ‚©‚ñ
5ŒŽ18“ú�i�…�j 10:30�`11:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- •½“c�@�Kˆê�iàÕ‹¦ˆã‰È‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ’Ò�@’å�r�iŽY‹Æˆã‰È‘åŠw�_Œo“à‰È�j
- ƒzƒbƒgƒgƒsƒbƒNƒX4�@ƒp�[ƒLƒ“ƒ\ƒ“•aŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2011
5ŒŽ19“ú�i–Ø�j 8:30�`9:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- �‚‹´�@—Ç•ã�i‹ž“s‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È—Õ�°�_ŒoŠw�j
- ‰‰ŽÒ�F
- •�“c�@“Ä�i“Œ–k‘åŠw•a‰@�_Œo“à‰È�j
- ƒzƒbƒgƒgƒsƒbƒNƒX5�@Ž©ŒÈ�R‘Ì‚©‚ç‚Ý‚½ƒjƒ…�[ƒ�ƒpƒ`�[
5ŒŽ19“ú�i–Ø�j 9:30�`10:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ŒIŽR�@�Ÿ�i”]�_ŒoƒZƒ“ƒ^�[‘å“c‹L”O•a‰@�j
- ‰‰ŽÒ�F
- “í�@�i�i‹ß‹E‘åŠw�_Œo“à‰È�j
- ƒzƒbƒgƒgƒsƒbƒNƒX6�@�_Œo“à‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“�G‘½”�«�d‰»�Ç
5ŒŽ19“ú�i–Ø�j 10:30�`11:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- –쑺�@‹±ˆê�i�é‹Êˆã‰È‘åŠw‘��‡ˆã—ÃZƒ“ƒ^�[�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‹g—Ç�@��ˆê�i‹ã�B‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@�_Œo“à‰È�j
- ƒzƒbƒgƒgƒsƒbƒNƒX7�@RNA splicingˆÙ�í‚Æ�_Œo޾г
5ŒŽ19“ú�i–Ø�j 13:15�`14:05�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ‰ºà_�@�r�iŽD–yˆã‰È‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ‘å–ì�@‹ÔŽi�i–¼ŒÃ‰®‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œoˆâ“`�î•ñŠw�j
- ƒzƒbƒgƒgƒsƒbƒNƒX8�@ALS‚Ì•a—��F�Å�V‚Ì’mŒ©
5ŒŽ20“ú�i‹à�j 8:30�`9:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- Š‹Œ´�@–ÎŽ÷�i—鎈ã—ÉȊw‘åŠw•ÛŒ’‰q�¶Šw•”ˆã—ÕŸŽƒŠw‰È�j
- ‰‰ŽÒ�F
- ‘ºŽR�@”É—Y�i“Œ‹ž“sŒ’�N’·Žõˆã—ÃZƒ“ƒ^�[�‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒN�j
- ƒzƒbƒgƒgƒsƒbƒNƒX9�@�_Œo“à‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“�G”F’m�Ç
5ŒŽ20“ú�i‹à�j 9:30�`10:20�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- �´�…�@‹P•v�i’鋞‘åŠwˆãŠw•”�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ’†“‡�@Œ’“ñ�i’¹Žæ‘åŠwˆãŠw•”ˆãŠw‰È”]�_Œoˆã‰ÈŠw�u�À”]�_Œo“à‰ÈŠw•ª–ì�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
ƒjƒ…�[ƒ�ƒTƒCƒGƒ“ƒXƒZƒbƒVƒ‡ƒ“
- ƒjƒ…�[ƒ�ƒTƒCƒGƒ“ƒXƒZƒbƒVƒ‡ƒ“1
Lee Silverman Voice Treatment; Rehabilitative Therapy for People with Parkinson�fs
5ŒŽ19“ú�i–Ø�j 10:45�`11:30�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- ‘º“c�@”ü•ä�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�j
- ‰‰ŽÒ�F
- Cynthia M Fox�iNational Center for Voice and Speech�j
- ƒjƒ…�[ƒ�ƒTƒCƒGƒ“ƒXƒZƒbƒVƒ‡ƒ“2�@ƒp�[ƒLƒ“ƒ\ƒ“�ÇŒó‚ð•û’öŽ®‚Å‰ð‚±‚¤
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@1B‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº131�{132�j
- �À’·�F
- �¬–쎛�@�G�i�¼‘½‰ê•a‰@�_Œo“à‰È�j
- ‰‰ŽÒ�F
- �²ŒÃ“c�@ŽO˜Y�i�‘—§•a‰@‹@�\“��ªŽR•a‰@�j
- ƒjƒ…�[ƒ�ƒTƒCƒGƒ“ƒXƒZƒbƒVƒ‡ƒ“3�@�_ŒoƒCƒ��[ƒWƒ“ƒOŽè–@‚ð—p‚¢‚½Šç”F’m‹@�\‚̉ð–¾
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@1C‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº133�{134�j
- �À’·�F
- ”ò�¼�@�ÈŽO�i‹ã�B‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@”]Œ¤—Õ�°�_Œo�¶—��j
- ‰‰ŽÒ�F
- Š`–Ø�@—²‰î�i�¶—�ŠwŒ¤‹†�Š“��‡�¶—�Œ¤‹†Œn�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
AAN-JSN Joint Symposium�i“ú•Ä�_ŒoŠw‰ï�‡“¯ƒVƒ“ƒ|ƒWƒEƒ€�j
- Keynote Session
5ŒŽ18“ú�i�…�j 14:30�`15:00�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ‹ààV�@ˆê˜Y�i“ú–{Šw�p‰ï‹c‰ï’·�C�‘�Ûˆã—ÕŸŽƒ‘åŠw‘åŠw‰@‘åŠw‰@’·�j
- JS-K-1
- The Japanese Society of Neurology and the American Academy of Neurology:Response to Global Imperatives
Robert Griggs�iPresident of American Academy of Neurology; Department of Neurology, University of Rochester School of Medicine and Dentistry, USA�j
- JS-K-2
- American Academy of Neurology (AAN) and Japanese Society of Neurology (JSN) �FBeyond the Pacific
�…àV�@‰p—m�i“ú–{�_ŒoŠw‰ï‘ã•\—�Ž–�C“Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@”]�_Œo•a‘ÔŠw•ª–ì�j
- 1�DALS
5ŒŽ18“ú�i�…�j 15:00�`16:45�@1A‰ï�ê�i1�†ŠÙ2ŠKƒZƒ“ƒ`ƒ…ƒŠ�[ƒz�[ƒ‹�j
- �À’·�F
- ‘c•ƒ�]�@Œ³�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
-
- Don W. Cleveland�iLudnig institute, University of California at San Diego, USA�j
- JS-1-1
- Clinical or Patient-Oriented Research to Find the Pathogeneses and Cause of ALS
ŽO–{�@”Ž�iDepartment of Neurology, Columbia University, USA�j
- JS-1-2
- The basis for selective neuronal vulnerability in ALS:mechanisms and therapy for ALS
Don W. Cleveland�iLudwig Institute, University of California at San Diego, USA�j
- JS-1-3
- Oligodendroglia are an unexpected major contributor to ALS and Neurodegeneration
Jeffrey D. Rothstein�iJohns Hopkins University, USA�j
- JS-1-4
- Optineurin in ALS
�ì�ã�@�GŽj�i�L“‡‘åŠwŒ´”š•úŽË�üˆã‰ÈŠwŒ¤‹†�Š�j
- JS-1-5
- Failure of RNA editing and the pathogenesis of ALS
Šs�@�L�i“Œ‹ž‘åŠw�_Œo“à‰È�j
- 2�DƒAƒ‹ƒcƒnƒCƒ}�[•a
5ŒŽ18“ú�i�…�j 15:00�`16:45�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- Šâ’Ø�@ˆÐ�i“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo•a—�Šw�j
-
- Michael W. Weiner�iDepartment of Radiology, San Francisco VA Medical Center/UCSF, USA�j
- JS-2-1
- Mechanisms and Treatment of Neuronal Dysfunction in Models of Alzheimer�fs Disease
Lennart Mucke�iGladstone Institute of Neurological Disease and UCSF, USA�j
- JS-2-2
- Biomakers for Predicting and Monitoring Progression of Alzheimer�fs Disease:The Alzheimer�fs Disease Neuroimaging Initiative
Michael W. Weiner�iDepartment of Radiology, San Francisco VA Medical Center/UCSF, USA�j
- JS-2-3
- Molecular pathology and disease-modifying therapies for Alzheimer�fs disease
Šâ’Ø�@ˆÐ�i“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo•a—�Šw�j
- JS-2-4
- The future of Alzheimer�fs disease:opportunities and challenges in drug development
“¡–{�@—zŽq�iƒtƒ@ƒCƒU�[�»–òДޮ‰ïŽÐŠJ”•”�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
 |
- East Asian Neurology Forum ‚ÍThe Movement Disorder Society ‚ÌŒö”Fƒvƒ�ƒOƒ‰ƒ€‚Å‚·�B
|
East Asian Neurology Forum
- Keynote Session
5ŒŽ19“ú�i–Ø�j 13:10�`14:40�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- –Ø‘º�@�~�iDepartment of Neurology, University of Iowa, USA�j
-
- �‚‹´�@—Ç•ã�i‹ž“s‘åŠw�_Œo“à‰È�j
- EA-K-1
- Message from the WCN to the East Asian Neurology
Mostafa El Alaoui Faris�iPresident of the 20th World Congress of Neurology, Marrakesh, 2011, Morocco�j
- EA-K-2
- Role of the CSN in East Asia
Liying Cui�iFormer President of the Chinese Society of Neurology, China�j
- EA-K-3
- Role of the KNA in East Asia
Beom S. Jeon�iInternational Delegate of the Korean Neurological Association, Korea�j
- EA-K-4
- Role of the JSN in East Asia
�…àV�@‰p—m�i“ú–{�_ŒoŠw‰ï‘ã•\—�Ž–�C“Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@”]�_Œo•a‘ÔŠw•ª–ì�j
- EA-K-5
- Žw’蔌¾
Š��@—´™Z�i�¢ŠE�_ŒoŠw˜A–¿—�Ž–�C“¿“‡‘åŠw�_Œo“à‰È�j
5ŒŽ19“ú�i–Ø�j 14:40�`16:45�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- ŽR–{�@Œõ—˜�i���쌧—§’†‰›•a‰@�_Œo“à‰È�j
-
- Beom S. Jeon�iSeoul National University Hospital, Korea�j
- Žw’蔌¾
- Accelerating the Cure for Parkinson�fs Disease:MJFF Mission and Funding Philosophy
Mark Frasier�iResearch Programs, Michael J Fox Foundation for Parkinson�fs Research, USA�j
Parkinsonism�Fup-to-date
- EA-1-1
- Neuroimaging and Diagnosis of Parkinsonism
Chong S. Lee�iASAN Medical Center, Korea�j
- EA-1-2
- Treatment of early Parkinson�fs disease
Louis Tan�iNational Neuroscience Institute, Singapore�j
- EA-1-3
- Treatment of advanced Parkinson�fs disease
Shu-Leong Ho�iUniversity of Hong Kong Queen Mary Hospital, Hong Kong�j
- EA-1-4
- Non-motor feature in Parkinson�fs disease
‘O“c�@“N–ç�i�H“cŒ§—§”]ŒŒŠÇŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰ÈŠwŒ¤‹†•”�j
- EA-1-5
- Genetics of Parkinson�fs disease in Asia
Chin-Song Lu�iChang Gung Medical Center at Linkou, Taiwan�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
 |
- East Asian Neurology Forum: Poster Session ‚ÍThe Movement Disorder Society ‚ÌŒö”Fƒvƒ�ƒOƒ‰ƒ€‚Å‚·�B
|
East Asian Neurology Forum: Poster Session
5ŒŽ18“ú�i�…�j 16:45�`17:30�iŽ©—R“¢˜_�j/17:30�`18:30�iƒ|ƒXƒ^�[”•\�j
1E�iƒ|ƒXƒ^�[‘æ1�j‰ï�ê�i1�†ŠÙ1ŠKƒCƒxƒ“ƒgƒz�[ƒ‹�j
- �À’·�F
- ‘åŒF�@‘×”V�i�‡“V“°‘åŠwˆãŠw•”•�‘®�ɪ•a‰@”]�_Œo“à‰È�j
- EP-A-1
- The effect of IV amantadine on freezing of gait�ifog�jresistant to dopaminergic therapy
Young Eun Kim�iDepartments of Neurology and Movement Disorder Center, College of Medicine, Seoul National University�j
- EP-A-2
- Detecting falls and freezing with motion recorder in Parkinson�fs disease patients under daily life condition
Yasuyuki Okuma�iDepartment of Neurology, Juntendo University Shizuoka Hospital�j
- EP-A-3
- Relative significance of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism
Ji Young Yun�iDepartment of Neurology, Seoul National University Hospital�j
- EP-A-4
- First case with X-linked dystonia-parkinsonism�iXDP: DYT-3�eLubag�f�jimproved by bilateral pallidum stimulation in Japan
Katsuo Kimura�iDepartment of Neurology, Tokyo Metropolitan Neurological Hospital�j
- EP-A-5
- Role of serotonin receptor 2A gene variants in the impulsive compulsive behaviors in PD
Jee-Young Lee�iDepartment of Neurology, College of Medicine, Seoul National University Boramae Hospital; Parkinson Study Group, Seoul National University Hospital�j
- EP-A-6
- Improvement of pathological gambling following subthalamic nucleus stimulation for Parkinson�fs disease
Hidemoto Saiki�iDepartment of Neurology, Kitano Hospital, The Tazuke Kofukai Medical Institute�j
- EP-A-7
- The Benefit of STN�|DBS on Pain in Parkinson Disease: A 2�|Year Follow�|Up Study
Han-Joon Kim�iDepartments of Neurology and Movement Disorder Center, and Neuroscience Research Institute, BK21, College of Medicine, Seoul National University Hospital, Seoul, Korea; Parkinson Disease Study Group, Seoul National University Hospital, Seoul, Korea�j
- �À’·�F
- •ž•”�@�M�F�i�‡“V“°‘åŠwˆãŠw•”•�‘®�‡“V“°ˆã‰@”]�_Œo“à‰È�j
- EP-B-1
- Compound heterozygous rearrangements of parkin in early-onset parkinsonism
Yuanzhe Li�iResearch Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University�j
- EP-B-2
- Treatment of AD model mice with TAPIR-like monoclonal antibody 3.4A10
Haifeng Jin�iResearch Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine; Department of Diagnosis, Prevention and Treatment of Dementia, Juntendo University Graduate School of Medicine�j
- EP-B-3
- The role of dynactin-1 in autophagy: a regulator for autophagosome-lysosome fusion
Zhe Huang�iDepartment of Neurology, Nagoya University Graduate School of Medicine�j
- EP-B-4
- Prospective observations of cognitive function and plasma homocysteine level in Parkinson�fs disease
Tetsuya Maeda�iDepartment of Neurology, Research Institute for Brain and Blood Vessels Akita�j
- EP-B-5
- Hsp90 inhibitors ameliorates polyglutamine-mediated motor dysfunction in SBMA models
Qiang Qiang�iDepartment of Neurology, Nagoya University Graduate School of Medicine�j
- EP-B-6
- Clinical correlates of anterior flexion of the thoracolumbar spine in patients with Parkinson�fs disease
Kenichi Kashihara�iDepartment of Neurology, Okayama Kyokuto Hospital�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
ƒVƒ“ƒ|ƒWƒEƒ€
- ƒVƒ“ƒ|ƒWƒEƒ€1
- BAD ‚͂ǂ¤’è‹`‚µ�C‘Ήž‚·‚é‚©�GŠe�‘‚Ì�l‚¦•û
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@1B‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº131�{132�j
- �À’·�F
- ŽÂŒ´�@�K�l�i�‘‰ÆŒö–±ˆõ‹¤�Ï‘g�‡˜A�‡‰ï—§�ì•a‰@�_Œo“à‰È�j
-
- ’I‹´�@‹I•v�i�é‹Êˆã‰È‘åŠw�‘�Ûˆã—ÃZƒ“ƒ^�[”]‘²’†“à‰È�j
- SY-01-1
- ‰ä‚ª�‘‚É‚¨‚¯‚éBAD ‚ÌŒ»�ó�iJ�|BAD Registry ‚̉ð�Í‚©‚ç�j
�¯–ì�@�°•F�i“Œ‹ž“s�Ï�¶‰ï’†‰›•a‰@�_Œo“à‰È�j
- SY-01-2
- Branch atheromatous disease:an important cause of small subcortical infarction in Asia
Jong Sung Kim�iMedical college, University of Ulsan; Department of Neurology, Asan Medical Center; Stroke Center, Asan Medical Center, Korea�j
- SY-01-3
- Branch atheromatous disease:prognosis and management. The SPS3 experience
Oscar Benavente�iDivision of Neurology, University of British Columbia, Canada�j
- ƒVƒ“ƒ|ƒWƒEƒ€2
- ƒAƒ‹ƒcƒnƒCƒ}�[•a‚Ì•ªŽqŽ¡—Ã�í—ª�F�V‚µ‚¢Ž‹“_‚ð‹�‚ß‚Ä
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@1C‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº133�{134�j
- �À’·�F
- ‘唪–Ø�@•Û��i‹ã�B‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@”]Œ¤�_Œo“à‰È�j
-
- Œ´�@‰p•v�i�²‰ê‘åŠwˆãŠw•”�_Œo“à‰È�j
- SY-02-1
- �×–E“àƒAƒ~ƒ�ƒCƒhƒÀ‚¨‚æ‚ÑŽ_‰»ƒXƒgƒŒƒX‚ð•W“I‚Æ‚·‚鎡—Öò�FƒAƒ|ƒ‚ƒ‹ƒtƒBƒ“
‘唪–Ø�@•Û��i‹ã�B‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@”]Œ¤�_Œo“à‰È�j
- SY-02-2
- ƒAƒ‹ƒcƒnƒCƒ}�[•a‚ÆŠ¿•ûŽ¡—Ã
Œ´�@‰p•v�i�²‰ê‘åŠwˆãŠw•”�_Œo“à‰È�j
- SY-02-3
- •ªŽqƒVƒƒƒyƒ�ƒ“—U“±�܂̃Aƒ‹ƒcƒnƒCƒ}�[•aŽ¡—Âւ̉ž—p
�H“¡�@‹ª�i‘å�ã‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�¸�_ˆãŠw‹³Žº�j
- SY-02-4
- ƒAƒ~ƒ�ƒCƒhƒÀ‚Ì“Å�«ƒ^�[ƒ“�\‘¢‚ð”Fޝ‚·‚é�R‘̂̊J”
“ü�]�@ˆê�_�i‹ž“s‘åŠw”_ŠwŒ¤‹†‰È�H•i�¶•¨‰ÈŠw�ê�U�j
- ƒVƒ“ƒ|ƒWƒEƒ€3
- ’E�‘�«Ž¾Š³‚É‚¨‚¯‚éƒOƒŠƒAŠÔ‚¨‚æ‚уOƒŠƒA�Eƒjƒ…�[ƒ�ƒ“ŠÔ‘ŠŒÝ�ì—p‚Ì”j’]
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@2C‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº222�{223�j
- �À’·�F
- ‹g—Ç�@��ˆê�i‹ã�B‘åŠw�_Œo“à‰È�j
-
- Žà‘º�@–¾�¶�i–¼ŒÃ‰®‘åŠwŠÂ‹«ˆãŠwŒ¤‹†�Š�_Œo–Ɖu•ª–ì�j
- SY-03-1
- �_Œo‰ÈŠw‚©‚猩‚½’E�‘�«Ž¾Š³‚É‚¨‚¯‚é–Æ‰u�×–E�EƒOƒŠƒA�Eƒjƒ…�[ƒ�ƒ“ŠÔ‘ŠŒÝ�ì—p‚̈Ù�í
�…–ì�@“N–ç�i–¼ŒÃ‰®‘åŠwŠÂ‹«ˆãŠwŒ¤‹†�Š�_Œo–Ɖu•ª–ì�j
- SY-03-2
- MS/NMO‚̃‚ƒfƒ‹‚©‚ç‚Ý‚½’E�‘�«Ž¾Š³‚É‚¨‚¯‚é–Æ‰u�×–E�EƒOƒŠƒA�Eƒjƒ…�[ƒ�ƒ“ŠÔ‘ŠŒÝ�ì—p‚̈Ù�í
’†’Ò�@—TŽi�i‘å�ã‘åŠw�_Œo“à‰È�j
- SY-03-3
- Ž‹�_Œo�Ò�‘‰Š�C‘½”�«�d‰»�Ç�CBalo•a‚É‚¨‚¯‚éƒAƒXƒgƒ�ƒTƒCƒg�áŠQ‚Ì“Á’¥
�¼‰º�@‘ñ–ç�i‹ã�B‘åŠw—Õ�°�_Œo–ƉuŠw�j
- ƒVƒ“ƒ|ƒWƒEƒ€4
- �_Œo“à‰È—̈æ‚É‚¨‚¯‚é‘O•ûŒü“IƒRƒz�[ƒgŒ¤‹†‚©‚猩‚¦‚Ä‚«‚½‚à‚Ì
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- •ô�¼�@ˆê•v�i�‘—§�zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^�[�j
-
- ŽáŽR�@‹g�O�i�º˜a‘åŠw–¼—_‹³Žö�j
- SY-04-1
- ‹ØƒWƒXƒgƒ�ƒtƒB�[ƒŒƒWƒXƒgƒŠ�[�iRemudy�j�GгŽÒ‚ÌŽ©”“I“o˜^ƒVƒXƒeƒ€�\’z‚ÆŠCŠO‚Ƃ̘AŒg
’†‘º�@Ž¡‰ë�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰È�j
- SY-04-2
- JaCALS�GALS‚Ì�i�s�C—\Œã‹K’èˆöŽq
”M“c�@’¼Ž÷�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-04-3
- ”F’m�ǂ̃Rƒz�[ƒgŒ¤‹†�F‹vŽR’¬Œ¤‹†
�´Œ´�@—T�i‹ã�B‘åŠwŠÂ‹«ˆãŠw•ª–ì�j
- SY-04-4
- JAMSAC�FMSA‚ɑ΂·‚édisease�|modifying therapyŽÀŒ»‚Ì‚½‚߂̗Õ�°Ž¡Œ±ƒfƒUƒCƒ“
Žs�ì�@–í�¶Žq�iJAMSAC�iJapan MSA research consortium�j�C“Œ‹ž‘åŠw�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€5
- ‹ØƒWƒXƒgƒ�ƒtƒB�[�V‹KŽ¡—Ö@ŠJ”‚Ì�Å‘O�ü
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- �»“c�@–F�G�i�ì�èˆã‰È‘åŠw�_Œo“à‰ÈŠw�j
-
- �¼‘º�@Šìˆê˜Y�i’鋞‘åŠwˆãŠw•”�_Œo“à‰È�j
- SY-05-1
- ƒfƒ…ƒVƒFƒ“ƒkŒ^‚ɑ΂·‚éƒGƒLƒ\ƒ“ƒXƒLƒbƒvŽ¡—Ã
•�“c�@�Lˆê�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[ˆâ“`Žq޾гޡ—ÃŒ¤‹†•”�j
- SY-05-2
- •ŸŽRŒ^‹ØƒWƒXƒgƒ�ƒtƒB�[‚Ì�V‚½‚È•a‘Ô�EŽ¡—Ã�í—ª
ŒË“c�@’BŽj�i�_ŒË‘åŠw�_Œo“à‰È�j
- SY-05-3
- Large‚É‚æ‚郿�|ƒWƒXƒgƒ�ƒOƒŠƒJƒmƒpƒ`�[‚ɑ΂·‚鎡—Ö@‚ÌŠJ”
�Ä“¡�@Žj–¾�i’鋞‘åŠw�_Œo“à‰È�j
- SY-05-4
- �œŠi‹Ø�Ä�¶Ž¡—Ã
‘åàV�@—T�i�ì�èˆã‰È‘åŠw•�‘®•a‰@�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€6
- Brain�|machine interface‚͂ǂ±‚܂ʼn”\‚©�H
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- •ÐŽR�@‘טN�i“ú–{ˆã‰È‘åŠw�_Œo�E�t‘Ÿ�EäPŒ´•aƒŠƒEƒ}ƒ`“à‰È•”–å�j
-
- –{“c�@Šw�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�j
- SY-06-1
- �Ò�‘‘¹��Œã‚Ì‹@”\‰ñ•œ‹@�˜‚̉𖾂Ƌ@”\‚ð•₤�l�H�_Œo�Ú‘±
�¼‘º�@�K’j�i�¶—�ŠwŒ¤‹†�Š”F’m�s“®”’B‹@�\Œ¤‹†•”–å�j
- SY-06-2
- Real�|time NIRS‚É‚æ‚éƒjƒ…�[ƒ�ƒtƒB�[ƒhƒoƒbƒN‚ð—p‚¢‚½�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“
ŽOŒ´�@‰ëŽj�i�X”V‹{•a‰@�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Œ¤‹†•”�E�_Œo“à‰È�j
- SY-06-3
- �_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‚É‚¨‚¯‚é”ñ�N�P“IBrain-machine interface‚̉”\�«
‹��ê�@��ˆê�iŒcœä‹`�m‘åŠw—��HŠw•”�¶–½�î•ñŠw‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€7
- Atypical types of dementia”ñ“TŒ^”F’m�Ç
5ŒŽ19“ú�i–Ø�j 8:30�`10:30�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- Šâ“c�@�~�i“Œ‹ž‘åŠwˆãŠwŒnŒ¤‹†‰È�_Œo“à‰È�j
-
- ‰Í‘º�@–ž�i�º˜a‘åŠw“à‰ÈŠw�u�À�_Œo“à‰ÈŠw•”–å�j
- SY-07-1
- Dementia‚Ì•ªŽq•a‘Ô�FEpigeneticsŒ¤‹†‚©‚ç
Šâ“c�@�~�i“Œ‹ž‘åŠwˆãŠwŒnŒ¤‹†‰È�_Œo“à‰È�j
- SY-07-2
- ”ñ“TŒ^”F’m�ǂւ̗Õ�°“IƒAƒvƒ��[ƒ`
—é–Ø�@‹§Žq�iŽRŒ`‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�‚ŽŸ”]‹@”\�áŠQŠw�j
- SY-07-3
- ”玿�«‹U�«‹…–ƒáƒ‚É‚æ‚锘b�áŠQ‚Å”�Ç‚·‚é�_Œo•Ï�«Ž¾Š³
�ÎŒ´�@Œ’Ži�i�º˜a‘åŠw•a‰@�_Œo“à‰È�j
- SY-07-4
- Dementia with motor neuron disease
Michael J. Strong�iDepartment of Clinical Neurological Sciences, The Schulich School of Medicine & Dentistry, The University of Western Ontario, Canada�j
- ƒVƒ“ƒ|ƒWƒEƒ€8
- ’ɂ݂Ì�Å�V‚Ì•a‘Ô‚ÆŽ¡—Ã
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- ‹�“c�@‹��G�iˆ¤’mˆã‰È‘åŠwŠw�Û“I’ɂ݃Zƒ“ƒ^�[�j
-
- ”n�ê�@�³”V�i�Â�XŒ§—§’†‰›•a‰@�_Œo“à‰È�j
- SY-08-1
- Neuropathic pain-definition, mechanisms diagnosis and management
Ralf Baron�iDivision of Neurological Pain Research and Therapy, Department of Neurologie, Univesitäetsklinikum Schleswig-Holstein, Germany�j
- SY-08-2
- �Ò�‘�‘“àŽîá‡�pŒã‚Ì�Ò�‘�áŠQ�«áu’ɂ̕a‘Ô
’†‘º�@‰ë–ç�iŒcœä‹`�m‘åŠwˆãŠw•”�®Œ`ŠO‰È�j
- SY-08-3
- �_Œo�áŠQ�«áu’ɂ̕ۑ¶“IŽ¡—Ã
‹�“c�@‹��G�iˆ¤’mˆã‰È‘åŠwŠw�Û“I’ɂ݃Zƒ“ƒ^�[�j
- ƒVƒ“ƒ|ƒWƒEƒ€9
- ”玿‰º�«ŒŒŠÇ�áŠQ‚Ì•a‘Ô‚ÆŽ¡—Ã
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- “à–ì�@�½�iŒF–{‘åŠw‘åŠw‰@�¶–½‰ÈŠwŒ¤‹†•”�_Œo“à‰ÈŠw•ª–ì�j
-
- •y–{�@�G˜a�iŽO�d‘åŠw�_Œo•a‘Ô“à‰ÈŠw•ª–ì�j
- SY-09-1
- ”玿‰ºŒŒŠÇ�«”F’m�Ç�F”F’m�ÇŽ¾Š³‚É‚¨‚¯‚éˆÊ’u‚¯
•y–{�@�G˜a�iŽO�d‘åŠw�_Œo•a‘Ô“à‰ÈŠw•ª–ì�j
- SY-09-2
- TGF�|ƒÀƒtƒ@ƒ~ƒŠ�[ƒVƒOƒiƒ‹‚̈Ù�í‚Æ”]�¬ŒŒŠÇ•a�|CARASIL‚Ì•ªŽq•a‘Ԃ̉ð�Í‚©‚ç
�¬–쎛�@—��i�VŠƒ‘åŠw”]Œ¤‹†�Š•�‘®�¶–½‰ÈŠwƒŠƒ\�[ƒXŒ¤‹†ƒZƒ“ƒ^�[”]޾гƒŠƒ\�[ƒX‰ð�Í•”–å�j
- SY-09-3
- ”玿‰º�«ŒŒŠÇ�áŠQ‚Ì•a‘Ô‚ÆŽ¡—Ã�\CADASIL
“à–ì�@�½�iŒF–{‘åŠw‘åŠw‰@�¶–½‰ÈŠwŒ¤‹†•”�_Œo“à‰ÈŠw•ª–ì�j
- ƒVƒ“ƒ|ƒWƒEƒ€10
- —Õ�°‚ÆŒ¤‹†‚É–ð—§‚Â�Å�V‚ÌMRIŠw
5ŒŽ19“ú�i–Ø�j 13:15�`14:45�@4C‰ï�ê�i4�†ŠÙ3ŠK‰ï‹cŽº432�j
- �À’·�F
- �–Ø�@–ÎŽ÷�i�‡“V“°‘åŠw•úŽË�üˆãŠw�u�À�j
-
- �X�@‰x˜N�i“Œ–k‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�‚ŽŸ”]‹@”\�áŠQŠw•ª–ì�j
- SY-10-1
- MRI‚ÅŒ©‚¦‚é‚à‚Ì�G3.0T‚Æ1.5T‚Ƃ̑Δä
ŽO–Ø�@�K—Y�i‘å�ãŽs—§‘åŠw•úŽË�ü‰È�j
- SY-10-2
- �_Œo“à‰È—̈æ‚É‚¨‚¯‚éMRI‚ð—p‚¢‚½—Õ�°Œ¤‹†�|1–‡‚̉摜‚ð‚Ç‚¤•]‰¿‚·‚é‚©�|
ˆÉ“¡�@�²ˆê�i�ç—t‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰@ˆãŠw‹³ˆçŒ¤‹†Žº�j
- SY-10-3
- ŠgŽUMRI‚Ì—Õ�°‰ž—p
�–Ø�@–ÎŽ÷�i�‡“V“°‘åŠw•úŽË�üˆãŠw�u�À�j
- ƒVƒ“ƒ|ƒWƒEƒ€11
- �_Œo“à‰Èˆã‚ÌƒŠƒNƒ‹�[ƒg‚ÉŒq‚°‚é–¢—ˆ‚Ö‚Ì’ñŒ¾
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@2C‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº222�{223�j
- �À’·�F
- “¹—E�@Šw�iˆ¤’mˆã‰È‘åŠw�_Œo“à‰È�j
-
- ‰¡“c�@—²“¿�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw�_Œo“à‰È�j
Keynote Lecture Attracting the best and brightest to careers in neurology
Donald H. Silberberg�iUniversity of Pennsylvania, USA�j
- SY-11-1
- Medical Neurology/Critical Neurology
Š¡“c�@“T�¶�i�_ŒË‘åŠwˆãŠw•”•�‘®•a‰@�_Œo“à‰È�j
- SY-11-2
- Expert/Neurologist �`—Õ�°
“ŒŠC—Ñ�@в•v�i�O‘O‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È”]�_Œo“à‰ÈŠw�j
- SY-11-3
- Disease-oriented Neuroscience Researcher
–]ŒŽ�@�GŽ÷�i–k—¢‘åŠw�_Œo“à‰ÈŠw�j
- ƒVƒ“ƒ|ƒWƒEƒ€12
- ‹Ø‰ŠŒ¤‹†�ŋ߂Ì�i•à
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- �–Ø�@�³Žu�i“Œ–k‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo“à‰È�j
-
- �¼–ì�@ˆêŽO�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�ŠŽ¾•aŒ¤‹†‘æˆê•”�j
- SY-12-1
- ‹Ø‰ŠŠÖ˜AŽ©ŒÈ�R‘Ì
ŒK–¼�@�³—²�iŒcœä‹`�m‘åŠwƒŠƒEƒ}ƒ`“à‰È�j
- SY-12-2
- �RSRP�R‘Ì—z�«ƒ~ƒIƒpƒ`�[
—é–Ø�@�d–¾�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
- SY-12-3
- ••“ü‘Ì‹Ø‰Š‚Ì•a‘Ô‚Æ•p“x
—é–Ø�@’¼‹P�i“Œ–k‘åŠw•a‰@�_Œo“à‰È�j
- SY-12-4
- ‹Ø‰ŠŽ¡—ÂÌ�Å‘O�ü
�´�…�@���i“Œ‹ž‘åŠw•a‰@�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€13
- ŽŸ�¢‘ãƒV�[ƒPƒ“ƒT�[‚É‚æ‚é�_Œo޾г‚̉ð–¾
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- ’Ò�@�ÈŽŸ�i“Œ‹ž‘åŠw�_Œo“à‰È�j
-
- ŒË“c�@’BŽj�i�_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È�_Œo“à‰ÈŠw•ªŽq”]‰ÈŠw�j
- SY-13-1
- ƒp�[ƒ\ƒiƒ‹ƒQƒmƒ€Œ¤‹†‚̃I�[ƒo�[ƒrƒ…�[
ŒË“c�@’BŽj�i�_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È�_Œo“à‰ÈŠw•ªŽq”]‰ÈŠw�j
’Ò�@�ÈŽŸ�i“Œ‹ž‘åŠw�_Œo“à‰È�j
- SY-13-2
- ƒp�[ƒ\ƒiƒ‹ƒQƒmƒ€‚Ì�î•ñ‰ð�Í�FŒ»�ó‚Ì�®—�‚Æ“W–]
�X‰º�@�^ˆê�i“Œ‹ž‘åŠw�î•ñ�¶–½‰ÈŠw�ê�U�j
- SY-13-3
- ˆâ“`�«�_Œo޾г‚ÌŒ¤‹†�|Posterior column ataxia with retinitis pigmentosa�|
�ΉY�@�_”V�i“Œ‹ž‘åŠw�_Œo“à‰È�j
- SY-13-4
- ŒÇ”�«Ž¾Š³‚ÌŒ¤‹†�|ƒp�[ƒLƒ“ƒ\ƒ“•a
ŽOˆä�@�ƒ�i“Œ‹ž‘åŠw•a‰@�_Œo“à‰È�j
- SY-13-5
- ƒp�[ƒ\ƒiƒ‹ƒQƒmƒ€Œ¤‹†‚Ì—Ï—�“I‰Û‘è
‰Á“¡�@˜a�l�i‹ž“s‘åŠwƒQƒmƒ€ELSIƒ†ƒjƒbƒg�j
- ƒVƒ“ƒ|ƒWƒEƒ€14
- �_Œo•Ï�«‚ð‚Ç‚¤�l‚¦‚é‚©�H•a‘Ô—�‰ð‚ÉŽŠ‚é�ŋ߂Ì�i•à
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- ‘«—§�@�O–¾�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
-
- ŠÑ–¼�@�M�s�i—�‰»ŠwŒ¤‹†�Š�\‘¢�_Œo•a—�Œ¤‹†ƒ`�[ƒ€�j
- SY-14-1
- ‹Ã�W‘ÌŒ`�¬‚©‚ç‚Ý‚½�_Œo•Ï�«‹@�˜
ŠÑ–¼�@�M�s�i—�‰»ŠwŒ¤‹†�Š�\‘¢�_Œo•a—�Œ¤‹†ƒ`�[ƒ€�j
- SY-14-2
- DNA‘¹���C•œ‚©‚ç‚Ý‚½�_Œo•Ï�«‹@�˜
‰ªàV�@‹Ï�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw�j
- SY-14-3
- TGF�|ƒÀƒVƒOƒiƒ‹‚©‚ç‚Ý‚½�_Œo•Ï�«‹@�˜
�Ÿ–ì�@‰ë‰›�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-14-4
- Žá”N�«ƒp�[ƒLƒ“ƒ\ƒ“•a‚Ì•a‘Ô‰ð–¾�FƒCƒ“ƒXƒŠƒ“ŠJŒû‹@�\‚©‚ç‚»‚Ì•aˆö‚É”—‚é
•ž•”�@�M�F�i�‡“V“°‘åŠwˆãŠw•”•�‘®�‡“V“°ˆã‰@”]�_Œo“à‰È�j
- SY-14-5
- ƒ~ƒgƒRƒ“ƒhƒŠƒA‚©‚猩‚½�_Œo•Ï�«‹@�˜�\ƒp�[ƒLƒ“ƒ\ƒ“•a‚ð—á‚É�\
�¼“c�@Œ›”V�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š’`”’Ž¿‘ãŽÓŒ¤‹†Žº�j
- ƒVƒ“ƒ|ƒWƒEƒ€15
- �Å�V‚̂Ăñ‚©‚ñ‚Ì•a‘Ô‚ÆŽ¡—Ã�i‹¤�Ã�F“ú–{‚Ä‚ñ‚©‚ñŠw‰ï�j
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- Œ“Žq�@’¼�i�O‘O‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È�_Œo�¸�_ˆãŠw�u�À�j
-
- ’Ò�@’å�r�iŽY‹Æˆã‰È‘åŠw�_Œo“à‰È�j
- SY-15-1
- ‚Ä‚ñ‚©‚ñ‚̃LƒƒƒŠ�[ƒI�[ƒo�[гŽÒ‚Ì–â‘è
‘å’Ë�@èñŽq�i‰ªŽR‘åŠw•a‰@�¬Ž™�_Œo‰È�j
- SY-15-2
- ‚Ä‚ñ‚©‚ñ‚Ì–À‘–�_ŒoŽhŒƒ—Ö@
�ì�‡�@Œª‰î�i“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”]�_ŒoŠO‰È�j
- SY-15-3
- ‚Ä‚ñ‚©‚ñŒ¤‹†‚Ì�Å‘O�ü
’r“c�@�º•v�i‹ž“s‘åŠw•a‰@�_Œo“à‰È�j
- SY-15-4
- ‚Ä‚ñ‚©‚ñŽ¡—ÂÌ�Å‘O�ü
�d“¡�@аŽj�i‹ã�B‘åŠw•a‰@�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€16
- �S–[�ד®Š³ŽÒ‚Ì�R‹ÃŒÅ—Ö@�\�VŽž‘ã‚ւ̑Ήž�\
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- “àŽR�@�^ˆê˜Y�i“Œ‹ž�—Žqˆã‰È‘åŠw�_Œo“à‰È�j
-
- –î�â�@�³�O�i�‘—§•a‰@‹@�\‹ã�Bˆã—ÃZƒ“ƒ^�[”]ŒŒŠÇ�E�_Œo“à‰È�j
- SY-16-1
- �S–[�ד®‚Ì�VƒKƒCƒhƒ‰ƒCƒ“‚Æ“ú�í�f—Âւ̑Ήž
ŽR‰º�@•�Žu�i�S‘ŸŒŒŠÇŒ¤‹†�Š�zŠÂŠí“à‰È�j
- SY-16-2
- �S–[�ד®‚Æ”]�Ç�ð�Ç�F‹}�«ŠúŽ¡—Â̎À�Û‚Æ–â‘è“_
–î�â�@�³�O�i�‘—§•a‰@‹@�\‹ã�Bˆã—ÃZƒ“ƒ^�[”]ŒŒŠÇ�E�_Œo“à‰È�j
- SY-16-3
- ƒgƒ�ƒ“ƒrƒ“‘jŠQ–ò‚Ö‚ÌŠú‘Ò‚Æ–â‘è“_
“àŽR�@�^ˆê˜Y�i“Œ‹ž�—Žqˆã‰È‘åŠw�_Œo“à‰È�j
- SY-16-4
- Xa‘jŠQ–ò‚Ì�Å�V‚̃Gƒrƒfƒ“ƒX‚Æ“W–]
’·”ö�@‹B•F�i“Œ‹ž�—Žqˆã‰È‘åŠw�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€17
- “�«––�½�_Œo޾г‚ÌŽ¡—Ã�í—ª
5ŒŽ19“ú�i–Ø�j 14:45�`16:45�@4C‰ï�ê�i4�†ŠÙ3ŠK‰ï‹cŽº432�j
- �À’·�F
- �_“c�@—²�iŽRŒû‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È�_Œo“à‰È�j
-
- ’†�ì�@�³–@�i‹ž“s•{—§ˆã‰È‘åŠw�_Œo“à‰ÈŠw�j
Keynote Lecture Perspectives in refractory diabetic and amyloid small-fiber neuropathy
Gerard Said�iDepartment of Neurology Hospital de la Salpetriere, France�j
- SY-17-1
- –��«‰Š�Ç�«’E�‘�«‘½”�ªƒjƒ…�[ƒ�ƒpƒ`�[‚ÌŽ¡—Ô½‰ž�«
”Ñ“‡�@�³”Ž�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-17-2
- ƒVƒƒƒ‹ƒR�[�Eƒ}ƒŠ�[�EƒgƒD�[ƒX•a‚ÌŽ¡—Ã�í—ª
’†�ì�@�³–@�i‹ž“s•{—§ˆã‰È‘åŠw�_Œo“à‰ÈŠw�j
- SY-17-3
- ƒNƒ�ƒE�E�[�£�ÇŒóŒQ
ŒKŒ´�@‘��i�ç—t‘åŠw•a‰@�_Œo“à‰È�j
- SY-17-4
- ŒŒ‰t�_ŒoŠÖ–å‚ðƒ^�[ƒQƒbƒg‚Æ‚µ‚½Ž¡—Ã�í—ª
�_“c�@—²�iŽRŒû‘åŠw•a‰@�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€18
- �_Œo“ï•aгŽÒ‚Ì‘��‡“IŽx‰‡
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@1B‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº131�{132�j
- �À’·�F
- Ž…ŽR�@‘×�l�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�j
-
- �¡ˆä�@�®Žu�i�‘—§•a‰@‹@�\‹{�é•a‰@�_Œo“à‰È�j
- SY-18-1
- “ï•aƒlƒbƒgƒ��[ƒN‚Æ“ï•aгŽÒŽx‰‡
‹g—Ç�@��ˆê�i‹ã�B‘åŠw�_Œo“à‰È�j
- SY-18-2
- “ï•aгŽÒ‚ÌQOL
�¬�X�@“N•v�i�‘—§•a‰@‹@�\” �ª•a‰@�j
- SY-18-3
- �Ý‘î�_Œo“ï•aгŽÒ‚Ì�ЊQŽžŽx‰‡Œv‰æ
�¼àV�@�³–L�i�VŠƒ‘åŠw•a‰@”]Œ¤‹†�Š—Õ�°�_Œo‰ÈŠw•”–å�_Œo“à‰ÈŠw•ª–ì�j
- SY-18-4
- �u“ï•aгŽÒ‚Ì�g‚¶‚è‚Â�h‚ðˆç‚ÞŽx‰‡‚Ì�\’z‚ÉŒü‚¯‚Ä�vŒ¤‹†”Ç‚Ì�¬‰Ê‚Æ“Œ–k�EŠÖ“Œ‘å�k�Ђ̌oŒ±‚𓥂܂¦‚Ä
�¡ˆä�@�®Žu�i�‘—§•a‰@‹@�\‹{�é•a‰@�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€19
- ƒOƒŠƒA�×–E‚Æ�_Œo޾г
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@1C‰ï�ê�i1�†ŠÙ3ŠK‰ï‹cŽº133�{134�j
- �À’·�F
- Žà‘º�@–¾�¶�i–¼ŒÃ‰®‘åŠwŠÂ‹«ˆãŠwŒ¤‹†�Š�_Œo–Ɖu•ª–ì�j
-
- �¼ˆä�@�^�i‹à‘òˆã‰È‘åŠw�_Œo“à‰È�j
- SY-19-1
- ƒAƒ‹ƒcƒnƒCƒ}�[•a‚ƃ~ƒNƒ�ƒOƒŠƒA
”óŒû�@�^�l�i•úŽË�üˆãŠw‘��‡Œ¤‹†�Š•ªŽqƒCƒ��[ƒWƒ“ƒOŒ¤‹†ƒZƒ“ƒ^�[�j
- SY-19-2
- ”]‹•ŒŒ‚ƃAƒXƒgƒ�ƒTƒCƒg
�‚‹´�@œÄˆê�iŒcœä‹`�m‘åŠw�_Œo“à‰È�j
- SY-19-3
- ’E�‘‚ƃIƒŠƒSƒfƒ“ƒhƒ�ƒTƒCƒg
ˆÉ“¡�@�‚�s�iUniversity of California Davis/Shriners Hospitals for Children Northern California, Department of Neurology, USA�j
- ƒVƒ“ƒ|ƒWƒEƒ€20
- “�«�_ŒoŠ´�õ�Çupdate
5ŒŽ20“ú�i‹à�j 13:15�`14:55�@2C‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº222�{223�j
- �À’·�F
- ‹Tˆä�@‘��i“ú–{‘åŠwˆãŠw•”“à‰ÈŠwŒn�_Œo“à‰ÈŠw•ª–ì�j
-
- �…àV�@‰p—m�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@ˆãŽ•Šw‘��‡Œ¤‹†‰È”]�_Œo•a‘ÔŠw�i�_Œo“à‰ÈŠw�j�j
- SY-20-1
- ’P�ƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŠ´�õ�Ç
‹Tˆä�@‘��i“ú–{‘åŠwˆãŠw•”“à‰ÈŠwŒn�_Œo“à‰ÈŠw•ª–ì�j
- SY-20-2
- HAMƒXƒyƒNƒgƒ‰ƒ€
‹v•Û“c�@—´“ñ�iŽŽ™“‡‘åŠw“ƒEƒCƒ‹ƒX•a‘Ô�§ŒäŒ¤‹†ƒZƒ“ƒ^�[�j
- SY-20-3
- ˆŸ‹}�«�d‰»�«‘S”]‰Š
�×–î�@Œõ—º�i•Ÿ“‡Œ§—§ˆã‰È‘åŠw�¬Ž™‰È�j
- SY-20-4
- �i�s�«‘½‘ƒ�«”’Ž¿”]�Ç�iPML�j
�…àV�@‰p—m�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@ˆãŽ•Šw‘��‡Œ¤‹†‰È”]�_Œo•a‘ÔŠw�i�_Œo“à‰ÈŠw�j�j
- ƒVƒ“ƒ|ƒWƒEƒ€21
- �_Œo•Ï�«Ž¾Š³‚Æ”]‘²’†‚ÌƒŠƒnƒrƒŠ�G—�˜_‚ÆŽÀ‘H
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- �¶‹î�@ˆêŒ›�i–kŠC“¹‘åŠwƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‰È�j
-
- ‹{ˆä�@ˆê˜Y�i�X”V‹{•a‰@�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Œ¤‹†•”�j
- SY-21-1
- ”]‘¹��Œã‚Ì‹@”\‰ñ•œ‚Ì”]“à‹@�\‚Æ�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“
‹{ˆä�@ˆê˜Y�i�X”V‹{•a‰@�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Œ¤‹†•”�j
- SY-21-2
- ‹}�«Šú‚©‚çŠJŽn‚·‚é”]‘²’†ƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‚Ì—�˜_‚ÆŽÀ�Û
Œ´�@а”ü�i‘ŠàV•a‰@ƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‰È�j
- SY-21-3
- �_Œo޾г‚ɑ΂·‚郊ƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‚Ì—�˜_‚ÆŽÀ‘H
Œ´�@�s�O�i“ú–{ˆã‰È‘åŠw�ç—t–k‘�•a‰@ƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€22
- “�«š‹‰º�áŠQ‚ɑ΂·‚鎡—Ã�í—ª�i‹¤�Ã�F“ú–{š‹‰ºˆãŠw‰ï�j
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- ˆä�ã�@�¹Œ[�iŽD–yŽR‚Ì�ã•a‰@�j
-
- “¡“‡�@ˆê˜Y�i•l�¼ŽsƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“•a‰@�j
- SY-22-1
- “�«š‹‰º�áŠQ‚ɑ΂·‚鎡—Ã�í—ª‘�˜_�CƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“�CŽè�p
“¡“‡�@ˆê˜Y�i•l�¼ŽsƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“•a‰@�j
- SY-22-2
- ”]‘²’†‚É‚æ‚éš‹‰º�áŠQ‚ɂ‚¢‚ÄWallenberg�ÇŒóŒQ�i‰„�‘ŠO‘¤�[�Ç�j‚ð’†�S‚É
‹�“‡�@•¶Žq�i‹ž“s‘æˆê�Ô�\Žš•a‰@�_Œo“à‰È�j
- SY-22-3
- ƒp�[ƒLƒ“ƒ\ƒ“•a�C‹ØˆÞ�k�«‘¤�õ�d‰»�ǂɑ΂·‚éš‹‰º�áŠQ‚Ì•]‰¿‚Æ‘Î�ô
ŽR–{�@•q”V�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€23
- �_Œo޾г‚ɑ΂·‚é�×–EŽ¡—Â̊J”�`Œ»�ó‚Æ“W–]
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- �‚‹´�@—Ç•ã�i‹ž“s‘åŠw•a‰@�_Œo“à‰È�j
-
- �¼–{�@�¹‘×�i�L“‡‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È‘n�¶ˆã‰ÈŠw�ê�U•a‘Ô’T‹†ˆã‰ÈŠw�u�À”]�_Œo“à‰ÈŠw�i‘æŽO“à‰È�j�j
- SY-23-1
- ’†�•�_Œo޾г‚ɑ΂·‚é�×–EŽ¡—Â̓W–]‚Ɖۑè�iƒI�[ƒo�[ƒrƒ…�[�j
�‚‹´�@—Ç•ã�i‹ž“s‘åŠw•a‰@�_Œo“à‰È�j
- SY-23-2
- iPS�×–E�ì�»‹Z�p‚ð—p‚¢‚½�_Œo•Ï�«Ž¾Š³‚ÌŒ¤‹†
ˆä�ã�@Ž¡‹v�i‹ž“s‘åŠwiPS�×–EŒ¤‹†�Š—Õ�°‰ž—pŒ¤‹†•”–å�j
- SY-23-3
- �_Œo•ª‰»‚Æ‘¢Žîá‡�«‚©‚ç”—‚éƒqƒgiPS�×–E‚Ì•iŽ¿•]‰¿
‰ª“c�@—m•½�iŒcœä‹`�m‘åŠw�¶—�Šw�j
- SY-23-4
- �SŒ´�«”]�Ç�ð�ÇŠ³ŽÒ‚ɑ΂·‚鎩ŒÈ�œ�‘’PŠj‹…‚ð—p‚¢‚½�×–EŽ¡—Â̗Õ�°ŽŽŒ±
“cŒû�@–¾•F�i�‘—§�zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^�[”]�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€24
- ‘n–òŒ¤‹†‚ð�„�i‚·‚邽‚߂ɂ͉½‚ª•K—v‚©�H
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- ˆ¢•”�@�N“ñ�i‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘��‡Œ¤‹†‰È�_Œo•a‘Ô“à‰ÈŠw�i�_Œo“à‰È�j�j
-
- “c’†�@�ÍŒi�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-24-1
- ‹}‚ª‚Ήñ‚ê�F—Õ�°Œ¤‹†ˆã‚ÌŒú‚¢‘w‚̈ç�¬‚Í�C�«—ˆ‚Ì‘n–òŒ¤‹†‚ðŽx‚¦‚é
•ŸŒ´�@�rˆê�i‹ž“s‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰Èˆã—ÉuŠw•ª–ì�j
- SY-24-2
- ƒAƒJƒfƒ~ƒA‚Å‚Ì�æ’[‘n–ò�E‘�Šú’T�õ“I—Õ�°ŠJ”
‹{“c�@•q’j�i“Œ–k‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È•�‘®‘n�¶‰ž—pˆãŠwŒ¤‹†ƒZƒ“ƒ^�[�j
- SY-24-3
- “ú–{‚ÆŠCŠO‚É‚¨‚¯‚é—Õ�°ŽŽŒ±‚ÌŽÀ�î‚Æ�¡Œã‚Ì“W–]
ˆêŠÛ�@�Ÿ•F�iˆã–ò•iˆã—Ë@Ší‘��‡‹@�\�V–ò�R�¸‘æŽO•”�j
- ƒVƒ“ƒ|ƒWƒEƒ€25
- ‚߂܂¢‚Ì—Õ�°�F�ŋ߂Ì�i•à
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- œA�£�@Œ¹“ñ˜Y�i�óƒm�ì‘��‡•a‰@”]�_ŒoƒZƒ“ƒ^�[�j
-
- •Ÿ•��@•q•v�i‹T“cƒ�ƒfƒBƒJƒ‹ƒZƒ“ƒ^�[�_Œo“à‰È�j
- SY-25-1
- ƒI�[ƒo�[ƒrƒ…�[�F‚߂܂¢‚Ì—Õ�°‚ð—�‰ð‚µ‚悤
œA�£�@Œ¹“ñ˜Y�i�óƒm�ì‘��‡•a‰@”]�_ŒoƒZƒ“ƒ^�[�j
- SY-25-2
- —Ç�«”�ì�«“ªˆÊ‚߂܂¢�Ç�\�f’f‚ÆŽ¡—ÂÌ�i•à
—é–Ø�@åÊ�i“Œ‹žˆã‰È‘åŠwލ•@ˆô�A‰ÈŠw‹³Žº�j
- SY-25-3
- ”]в�E�¬”]‚ÌŒŒŠÇ�áŠQ‚É‚æ‚é‚߂܂¢
�é‘q�@Œ’�i•½’Ë‹¤�Ï•a‰@�_Œo“à‰È�j
- SY-25-4
- ƒqƒg‚Ì‘O’ë”玿
“à“¡�@‘×�i�_ŒËŽs—§ˆã—ÃZƒ“ƒ^�[’†‰›Žs–¯•a‰@ލ•@ˆô�A‰È�j
- SY-25-5
- ‚܂Ƃß
•Ÿ•��@•q•v�i‹T“cƒ�ƒfƒBƒJƒ‹ƒZƒ“ƒ^�[�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€26
- •Ï�«Ž¾Š³‚̃V�[ƒh�E‹Ã�W�E�_Œo‰ñ˜H–Ô“`”À‰¼�à‚ÌŒŸ�Ø
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- ’·’J�ì�@�¬�l�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š”F’m�ǃvƒ�ƒWƒFƒNƒg�j
-
- ‘ºŽR�@”É—Y�i“Œ‹ž“sŒ’�N’·Žõˆã—ÃZƒ“ƒ^�[�‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒN�j
- SY-26-1
- �˜Œ¾�F�‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒNƒvƒ�ƒWƒFƒNƒg‚©‚ç‚ÌŽxŽ�
‘ºŽR�@”É—Y�i“Œ‹ž“sŒ’�N’·Žõˆã—ÃZƒ“ƒ^�[�‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒN�j
- SY-26-2
- ƒvƒŠƒIƒ“•a‚©‚ç‚Ý‚½Š´�õ‚·‚é’`”’‚Æ‚Í�\Œ´“_‚Æ‚µ‚ẴvƒŠƒIƒ“•aup to date�\
–k–{�@“N”V�i“Œ–k‘åŠwˆãŠwŒnŒ¤‹†‰È•a‘Ô�_ŒoŠw�j
- SY-26-3
- �_Œo•Ï�«Ž¾Š³‚É‚¨‚¯‚é’`”’Šà‰¼�à
’·’J�ì�@�¬�l�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š”F’m�ǃvƒ�ƒWƒFƒNƒg�j
- SY-26-4
- ƒnƒ“ƒ`ƒ“ƒgƒ“•a‚Å‚Ì�¸�_�áŠQ”Œ»‚É‚¨‚¯‚éƒNƒ�ƒXƒV�[ƒfƒBƒ“ƒO‰¼�à�\ƒvƒŠƒIƒ“•a‚©‚ç�¸�_�E�_Œo޾г‚Ö‚Ì“W–]�\
“c’†�@Œ³‰ë�i—�‰»ŠwŒ¤‹†�Š”]‰ÈŠw‘��‡Œ¤‹†ƒZƒ“ƒ^�[“c’†Œ¤‹†ƒ†ƒjƒbƒg�j
- ƒVƒ“ƒ|ƒWƒEƒ€27
- ƒI�[ƒgƒtƒ@ƒW�[‚Æ�_Œo•Ï�«‚ð‚ß‚®‚Á‚Ä�F•a‘Ô‚©‚玡—ÂÖ
5ŒŽ20“ú�i‹à�j 13:15�`14:45�@4C‰ï�ê�i4�†ŠÙ3ŠK‰ï‹cŽº432�j
- �À’·�F
- �¬�¼�@‰ë–¾�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š�j
-
- ‰iˆä�@‹`—²�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�ŠŽ¾•aŒ¤‹†‘æŽl•”�j
- SY-27-1
- ƒXƒgƒŒƒX‰ž“š‹@�\‚Æ‚µ‚Ă̑I‘ð“IƒI�[ƒgƒtƒ@ƒW�[
�¬�¼�@‰ë–¾�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š�j
- SY-27-2
- •a“IƒAƒ“ƒhƒ�ƒQƒ“Žó—e‘Ì‚Ì�¶‘Ì“à•ª‰ðŒn‚ð—˜—p‚µ‚½‘|“¢
‘«—§�@�O–¾�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-27-3
- QBP1‚ð‰ž—p‚µ‚½ˆÙ�í�L’·ƒ|ƒŠƒOƒ‹ƒ^ƒ~ƒ“’`”’Ž¿‚Ì“ÁˆÙ“I•ª‰ð
‰iˆä�@‹`—²�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�ŠŽ¾•aŒ¤‹†‘æŽl•”�j
- ƒVƒ“ƒ|ƒWƒEƒ€28
- “d‹C�¶—�‚©‚ç‚Ý‚½ALS‚Ì•a‘Ôupdate
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@2C‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº222�{223�j
- �À’·�F
- ŒKŒ´�@‘��i�ç—t‘åŠw�_Œo“à‰È�j
-
- ‰€�¶�@‰ë�O�i’鋞‘åŠw�_Œo“à‰È�j
- SY-28-1
- ALS‚Ì“d‹C�¶—�Šw“I�f’f‚ÌŽÀ�Û
‰€�¶�@‰ë�O�i’鋞‘åŠw�_Œo“à‰È�j
- SY-28-2
- ALS‚ł͉^“®�_Œo޲�õ‚Ì–Œ“dˆÊ•Ï“®‚ª‘å‚«‚¢
“‡’J�@‰ÀŒõ�i“¿“‡‘åŠw•a‰@�_Œo“à‰È�j
- SY-28-3
- ALS‚Ì—\Œã‹K’èˆöŽq‚Æ‚µ‚Ẳ^“®�_Œo޲�õ–Œ‹»•±“Á�«
‹àˆä�@�”–¾�i�ç—t‘åŠwˆãŠw•”•�‘®•a‰@�_Œo“à‰È�j
- SY-28-4
- TDP-43‹�§”Œ»“®•¨ƒ‚ƒfƒ‹‚É‚¨‚¯‚é•a—��E“d‹C�¶—�
‰¡“c�@—²“¿�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€29
- �Ò�‘�¬”]•Ï�«�Çupdate
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@2D‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº224�j
- �À’·�F
- �²�X–Ø�@�G’¼�i–kŠC“¹‘åŠwˆãŠwŒ¤‹†‰È�_Œo“à‰È�j
-
- �¼àV�@�³–L�i�VŠƒ‘åŠw•a‰@”]Œ¤‹†�Š�_Œo“à‰ÈŠw•ª–ì�j
- SY-29-1
- �¬”]‹@”\‚Ì�¶—�Šw“I‰ð�Í�FŽžŠÔ•\Œ»‚̃�ƒJƒjƒYƒ€
“c’†�@�^Ž÷�i–kŠC“¹‘åŠwˆãŠwŒ¤‹†‰È�¶—�Šw�u�À”F’m�s“®Šw•ª–ì�j
- SY-29-2
- SCA31‚Ì•ªŽq•a‘Ô‰ð–¾
�Î�ì�@‹Ô–ç�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw�_Œo“à‰È�j
- SY-29-3
- ‚킪�‘‚É‚¨‚¯‚éˆâ“`�«áz�«‘Ζƒáƒ‚ÌŒ»�ó
‘ëŽR�@‰Ã‹v�iŽR—œ‘åŠwˆãŠw•”�_Œo“à‰ÈŠw�u�À�j
- SY-29-4
- �¬”]�«‰^“®Ž¸’²‚ɑ΂·‚郊ƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‚Ì—LŒø�«
‹{ˆä�@ˆê˜Y�i�X”V‹{•a‰@�_ŒoƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Œ¤‹†•”�j
- ƒVƒ“ƒ|ƒWƒEƒ€30
- ƒAƒ~ƒ�ƒCƒh�[ƒVƒXupdate
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@2E‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº232�{233�j
- �À’·�F
- ’r“c�@�Cˆê�i�M�B‘åŠwˆãŠw•””]�_Œo“à‰È�CƒŠƒEƒ}ƒ`�EäPŒ´•a“à‰È�j
-
- ŽR“c�@�³�m�i‹à‘ò‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”]˜V‰»�E�_Œo•a‘ÔŠw�i�_Œo“à‰ÈŠw�j�j
- SY-30-1
- ”ñ‰Æ‘°�«ƒAƒ~ƒ�ƒCƒh�[ƒVƒX‚Ì—Õ�°‚ƉuŠw
ŠÖ“‡�@—ÇŽ÷�i�M�B‘åŠwˆâ“`Žq�f—Õ”�j
- SY-30-2
- ‰Æ‘°�«ƒAƒ~ƒ�ƒCƒh�[ƒVƒX‚Ì—Õ�°‚Æ•a—�
�¬’r�@�tŽ÷�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-30-3
- ‰Æ‘°�«ƒAƒ~ƒ�ƒCƒhƒ|ƒŠƒjƒ…�[ƒ�ƒpƒ`�[�iFAP�j‚ɑ΂·‚éŠÌˆÚ�A‚Ì—L—p�«‚ÆŒÀŠE
ˆÀ“Œ�@—RŠì—Y�iŒF–{‘åŠw�¶–½‰ÈŠwŒ¤‹†•”•a‘Ô�î•ñ‰ð�ÍŠw�j
- SY-30-4
- ”]ƒAƒ~ƒ�ƒCƒhƒAƒ“ƒMƒIƒpƒ`�[‚Ì—Õ�°•a—�
ŽR“c�@�³�m�i‹à‘ò‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”]˜V‰»�E�_Œo•a‘ÔŠw�i�_Œo“à‰ÈŠw�j�j
- SY-30-5
- ƒAƒ~ƒ�ƒCƒh’`”’‚Ì‘ãŽÓ‰ñ“]‚ÆŽ¡—Âɂæ‚é‘Þ�k
’r“c�@�Cˆê�i�M�B‘åŠwˆãŠw•””]�_Œo“à‰È�CƒŠƒEƒ}ƒ`�EäPŒ´•a“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€31
- •Гª’ɂ̖��«‰»�C“‰»‚̃�ƒJƒjƒYƒ€‚ÆŽ¡—Ã
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@2F‰ï�ê�i2�†ŠÙ3ŠK‰ï‹cŽº234�j
- �À’·�F
- —é–Ø�@‘¥�G�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
-
- ’†“‡�@Œ’“ñ�i’¹Žæ‘åŠwˆãŠw•”ˆãŠw‰È”]�_Œoˆã‰ÈŠw�u�À”]�_Œo“à‰ÈŠw•ª–ì�j
- SY-31-1
- •Гª’É–��«‰»‚̃�ƒJƒjƒYƒ€
—é–Ø�@‘¥�G�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
- SY-31-2
- •Гª’ɂ̌o‰ß�EŽ©‘R—ð
ŒÃ˜a�@‹v“T�i’¹Žæ‘åŠw”]�_Œo“à‰È�j
- SY-31-3
- “�«–ò•¨—�—p“ª’ɂ̎¡—Ã
à_“c�@��ˆê�i–k—¢‘åŠwˆãŠw•”�_Œo“à‰ÈŠw�j
- SY-31-4
- �¸�_‰È�E�S—Óà‰È‚©‚ç‚̃Aƒvƒ��[ƒ`
’[‹l�@�ŸŒh�i“Œ–M‘åŠw‘å�X•a‰@�S—Óà‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€32
- �_Œo޾г‚ɑ΂·‚é�R‘̗Ö@
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@3A‰ï�ê�i3�†ŠÙ3ŠK�‘�Û‰ï‹cŽº�j
- �À’·�F
- “c•½�@•��i�‡“V“°‘åŠwˆãŠw•”•�‘®�‡“V“°ˆã‰@”]�_Œo“à‰È�j
-
- ŽR‘º�@—²�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�Š–Æ‰uŒ¤‹†•”�j
- SY-32-1
- MS/NMO‚ɑ΂·‚é�R‘̗Ö@‚̉”\�«
ŽR‘º�@—²�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�Š–Æ‰uŒ¤‹†•”�j
- SY-32-2
- ‹ØŽ¾Š³‚ɑ΂·‚é�Rƒ}ƒCƒIƒXƒ^ƒ`ƒ“�R‘̗Ö@‚ÌŠJ”‚Ɖž—p
�»“c�@–F�G�i�ì�èˆã‰È‘åŠw•a‰@�_Œo“à‰ÈŠw�j
- SY-32-3
- ƒAƒ‹ƒcƒnƒCƒ}�[•a‚ɑ΂·‚é�R‘̗Ö@
“c•½�@•��i�‡“V“°‘åŠwˆãŠw•”•�‘®�‡“V“°ˆã‰@”]�_Œo“à‰È�j
- SY-32-4
- ‹ØˆÞ�k�«‘¤�õ�d‰»�ǂɑ΂·‚é�R‘̗Ö@
޽’J�@�^�iŽ ‰êˆã‰È‘åŠw•ªŽq�_Œo‰ÈŠwŒ¤‹†ƒZƒ“ƒ^�[�j
- ƒVƒ“ƒ|ƒWƒEƒ€33
- ƒp�[ƒLƒ“ƒ\ƒ“•a‚Ì•a‘Ô‚©‚ç—Õ�°update
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@4A‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i–k�j�j
- �À’·�F
- •ž•”�@�M�F�i�‡“V“°‘åŠw”]�_Œo“à‰È�j
-
- ŽR–{�@Œõ—˜�i���쌧—§’†‰›•a‰@�_Œo“à‰È�j
- SY-33-1
- •a‘Ô
’·’J�ì�@—²•¶�i“Œ–k‘åŠw•a‰@�_Œo“à‰È�j
- SY-33-2
- •a—�
ꎓ¡�@—SŽq�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[•a‰@—Õ�°ŒŸ�¸•”�j
- SY-33-3
- ƒp�[ƒLƒ“ƒ\ƒ“•aŽ¡—ÂÌup�|to�|date
”g“c–ì�@‘ô�i�‡“V“°‘åŠwˆãŠw•”•�‘®�‡“V“°ˆã‰@”]�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€34
- ”]�[�Ç�FTissue clock ‚ÆReperfusion
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@4B‰ï�ê�i4�†ŠÙ1ŠK”’’¹ƒz�[ƒ‹�i“ì�j�j
- �À’·�F
- –Ø‘º�@˜a”ü�i�ì�èˆã‰È‘åŠw•a‰@”]‘²’†ˆãŠw�j
-
- �‚‹´�@œÄˆê�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
- SY-34-1
- Tissue clock ‚ÆReperfusion�FBrief overview
�‚‹´�@œÄˆê�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
- SY-34-2
- iv-tPAŽ¡—Ã4.5ŽžŠÔ‚܂łÌtime window‚ÆMRI‚Ì“WŠJ
–Ø‘º�@˜a”ü�i�ì�èˆã‰È‘åŠw•a‰@”]‘²’†ˆãŠw�j
- SY-34-3
- ”]“®–¬�ÄŠJ’ʗÖ@‚ÌŒ»�ó‚Æ�¡Œã
�âˆä�@�M�K�i�_ŒËŽs—§ˆã—ÃZƒ“ƒ^�[’†‰›Žs–¯•a‰@”]�_ŒoŠO‰È�j
- SY-34-4
- Tissue Clock Measurement Device‚Æ‚µ‚Ä‚ÌMRS
ŒÜ�\—’�@”Ž’†�i�VŠƒ‘åŠw”]Œ¤‹†�Š“��‡”]‹@”\Œ¤‹†ƒZƒ“ƒ^�[�j
- SY-34-5
- ”]�[�Ç‹}�«ŠúŽ¡—ÂÌtherapeutic time window
ˆ¢•”�@�N“ñ�i‰ªŽR‘åŠw�_Œo“à‰È�j
- ƒVƒ“ƒ|ƒWƒEƒ€35
- ‰^“®ƒjƒ…�[ƒ�ƒ“޾г‚Ì•ªŽq•a‘Ԃ̉𖾂Ǝ¡—Ö@ŠJ”‚Ö‚Ì“W–]
5ŒŽ20“ú�i‹à�j 15:00�`17:00�@4C‰ï�ê�i4�†ŠÙ3ŠK‰ï‹cŽº432�j
- �À’·�F
- Š��@—´™Z�i“¿“‡‘åŠw�_Œo“à‰È�j
-
- �Ÿ–ì�@‰ë‰›�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-35-1
- TDP-43‚É‚æ‚é‰^“®ƒjƒ…�[ƒ�ƒ“•Ï�«‚Ì•ªŽq•a‘Ô
–ì’†�@—²�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š�j
- SY-35-2
- Seipinopathy/Seipin/BSCL2ŠÖ˜A‰^“®ƒjƒ…�[ƒ�ƒ“޾г�\�_Œo•Ï�«‚É‚¨‚¯‚é�¬–E‘̃XƒgƒŒƒX‚Ì�d—v�«�\
ˆÉ“Œ�@‘å‰î�iŒcœä‹`�m‘åŠw•a‰@�_Œo“à‰È�j
- SY-35-3
- Dynactin�|1‚ð•W“I‚Æ‚µ‚½ŒÇ”�«ALSƒ‚ƒfƒ‹‚ÌŠJ”
“c’†�@�ÍŒi�i–¼ŒÃ‰®‘åŠw�_Œo“à‰È�j
- SY-35-4
- ALS ‚É‚¨‚¯‚éƒOƒŠƒAŠÖ˜A•a‘Ô
ŽR’†�@�G“ñ�i—�‰»ŠwŒ¤‹†�Š”]‰ÈŠw‘��‡Œ¤‹†ƒZƒ“ƒ^�[‰^“®ƒjƒ…�[ƒ�ƒ“•Ï�«Œ¤‹†ƒ`�[ƒ€�j
- SY-35-5
- ŠÌ�×–E‘��BˆöŽq‚É‚æ‚éALS‚ɑ΂·‚é�V‹KŽ¡—Ö@‚ÌŠJ”
�–Ø�@�³Žu�i“Œ–k‘åŠw•a‰@�_Œo“à‰È�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
ƒ`�[ƒ€ˆã—ÃŽÀ‘Hƒvƒ�ƒOƒ‰ƒ€
- ƒe�[ƒ}1�@�_Œo޾г‚É‚¨‚¯‚éƒPƒA‚ÌŽÀ‘H‚ÆƒŠƒXƒNƒ}ƒl�[ƒWƒ�ƒ“ƒg
5ŒŽ17“ú�i‰Î�j 13:00�`15:30�@2B‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº212�j
1�C“]“|—\–h
- �À’·�F
- ‹À�ê�@ˆèŽq�i�‘—§•a‰@‹@�\“Œ–¼ŒÃ‰®•a‰@�_Œo“à‰È�j
-
- �ìˆä�@�[�i“Œ�é‹Ê•a‰@�_Œo“à‰È�j
“]“|—\–h‚̃�ƒJƒjƒYƒ€
- ‰‰ŽÒ�F
- ‰œ�ò�@�G�N�i“ŒŒäŽs—§‚݂܂«‰·�ò�f—Ã�Š�j
�_Œo޾г‚É‚¨‚¯‚é“]“|‚Ì“Á’¥
- ‰‰ŽÒ�F
- ‹À�ê�@ˆèŽq�i�‘—§•a‰@‹@�\“Œ–¼ŒÃ‰®•a‰@�_Œo“à‰È�j
“]“|—\–h‘Î�ô‚ÆŽÀ‘H
- ‰‰ŽÒ�F
- ‘ºˆä�@“ÖŽq�i�‘—§•a‰@‹@�\“Œ–¼ŒÃ‰®•a‰@ŠÅŒì•”�j
“]“|—\–h‚Ì‚½‚ß‚ÌƒŠƒnƒrƒŠ
- ‰‰ŽÒ�F
- ˆ¢•”�@˜a•v�i‘å�ã•ÛŒ’ˆã—ÑåŠwŒ¤‹†Žx‰‡ƒZƒ“ƒ^�[�j
- ƒe�[ƒ}1�@�_Œo޾г‚É‚¨‚¯‚éƒPƒA‚ÌŽÀ‘H‚ÆƒŠƒXƒNƒ}ƒl�[ƒWƒ�ƒ“ƒg
5ŒŽ17“ú�i‰Î�j 15:45�`18:15�@2B‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº212�j
2�C‰h—{ŠÇ—�
- �À’·�F
- ‹{àV�@–õ�i‹ß�X•a‰@—Õ�°‰h—{•”�j
-
- ŽR‰ª�@˜NŽq�i�‘—§’·Žõˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰È�j
�_Œo޾ггŽÒ‚̉h—{ƒTƒ|�[ƒg
- ‰‰ŽÒ�F
- ‹{àV�@–õ�i‹ß�X•a‰@—Õ�°‰h—{•”�j
�_Œo޾г‚É‚¨‚¯‚é•a‘ԂƉh—{‰î“ü
- ‰‰ŽÒ�F
- ŽR‰ª�@˜NŽq�i�‘—§’·Žõˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰È�j
Œo’°‰h—{–@‚ÆŒo�Ö¬‰h—{–@
- ‰‰ŽÒ�F
- •Б½�@Žj–¾�i‹T“c‘��‡•a‰@�_Œo“à‰È�j
�_Œo޾г‚É‚¨‚¯‚éåñጂ̊Ǘ�
- ‰‰ŽÒ�F
- ˆéŠL�@‘P‘ �i�‘—§’·Žõˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�æ’[�f—Õ””畆‰È�j
- ƒe�[ƒ}2�@�‚ŽŸ”]‹@”\�áŠQ‚ɑ΂·‚éƒPƒA‚ÆƒŠƒnƒrƒŠ‚Ì�Å‘O�ü
5ŒŽ17“ú�i‰Î�j 14:00�`18:30�@2A‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº211�j
- �À’·�F
- •�“c�@�ÍŒh�i�‘—§’·Žõˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_Œo“à‰È�j
-
- ŽR–{�@�³•F�iˆ¤’mŠw‰@‘åŠw�S�g‰ÈŠw•”�j
�‚ŽŸ”]‹@”\�áŠQ‚̃PƒA‚ÆƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“
- ‰‰ŽÒ�F
- Ží‘º�@—¯”ü�i�_ŒË‘åŠw‘åŠw‰@•ÛŒ’ŠwŒ¤‹†‰È�j
”F’m�ǂ̃PƒA‚ÆƒŠƒnƒrƒŠ�F�_Œo“à‰È‚Ì—§�ê‚©‚ç
- ‰‰ŽÒ�F
- �¡‘º�@“O�i�VŠƒˆã—ÕŸŽƒ‘åŠw‘åŠw‰@ˆã—ÕŸŽƒŠwŒ¤‹†‰È•ÛŒ’Šw�ê�UŒ¾Œê’®ŠoŠw•ª–ì�j
”F’m�ǂ̃PƒA‚ÆƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“�G�¸�_‰È‚Ì—§�ê‚©‚ç
- ‰‰ŽÒ�F
- ŽO‘º�@›’�iŒcœä‹`�m‘åŠwˆãŠw•”�¸�_�_Œo‰È�j
ޏŒê�ǂ̃PƒA‚ÆƒŠƒnƒrƒŠ
- ‰‰ŽÒ�F
- ‘å’Î�@”ü‰À�i–kŠC“¹‘åŠw‘åŠw‰@•ÛŒ’‰ÈŠwŒ¤‹†�j
- ƒe�[ƒ}3�@CI—Ö@�K“¾ƒvƒ�ƒOƒ‰ƒ€
5ŒŽ17“ú�i‰Î�j 14:00�`16:30�@2C‰ï�ê�i2�†ŠÙ2ŠK‰ï‹cŽº222�{223�j
- �À’·�F
- ›�ŽìŽR�@–«�i–¼ŒÃ‰®‘åŠw•ÛŒ’Šw‰È�j
CI—Ö@�K“¾ƒZƒ~ƒi�[
- ‰‰ŽÒ�F
- “¹–Æ�@˜a‹v�i•ºŒÉˆã‰È‘åŠwƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“ˆãŠw‹³Žº�j
- ƒe�[ƒ}1�@�_Œo޾г‚É‚¨‚¯‚éƒPƒA‚ÌŽÀ‘H‚ÆƒŠƒXƒNƒ}ƒl�[ƒWƒ�ƒ“ƒg
5ŒŽ18“ú�i�…�j 8:30�`10:10�@2A‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº211�j
3�C�_Œo‹ØŽ¾Š³‚É‚¨‚¯‚éŒÄ‹zƒPƒA
- �À’·�F
- ’†“‡�@�F�i�‘—§•a‰@‹@�\�VŠƒ•a‰@�_Œo“à‰È�j
-
- •Ÿ‰i�@�G•q�i�‘—§•a‰@‹@�\“ì‹ã�B•a‰@�j
ŒÄ‹z•s‘S‚ɑ΂·‚éŒÄ‹zƒPƒA‘�˜_
- ‰‰ŽÒ�F
- ’±–¼—Ñ�@’¼•F�i�¹˜H‰Á�‘�Û•a‰@ŒÄ‹zŠí“à‰È�j
‹ØƒWƒXƒgƒ�ƒtƒB�[‚É‚¨‚¯‚éŒÄ‹zƒPƒA
- ‰‰ŽÒ�F
- �Î�ì�@—I‰Á�i�‘—§•a‰@‹@�\”ª‰_•a‰@�¬Ž™‰È�j
ALS‚̕“IŒÄ‹zƒPƒA
- ‰‰ŽÒ�F
- �¬�X�@“N•v�i�‘—§•a‰@‹@�\” �ª•a‰@�j
�_Œo‹ØŽ¾Š³‚̌ċzŠíƒPƒA‚É‚¨‚¯‚é—�Šw—Ö@‚Ì–ðŠ„
- ‰‰ŽÒ�F
- ‹e’n�@–L�i”]ŒŒŠÇŒ¤‹†�Š”üŒ´‹L”O•a‰@�_Œo“ï•aƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“‰È�j
ŒÄ‹zƒPƒA‚É‚¨‚¯‚éŠÅŒìƒPƒA‚Ì–ðŠ„
- ‰‰ŽÒ�F
- ’†ŽR�@—D‹G�i“Œ‹ž“sˆãŠw‘��‡Œ¤‹†�Š“ï•aƒPƒAŠÅŒìŒ¤‹†•”–å�j
- ƒe�[ƒ}1�@�_Œo޾г‚É‚¨‚¯‚éƒPƒA‚ÌŽÀ‘H‚ÆƒŠƒXƒNƒ}ƒl�[ƒWƒ�ƒ“ƒg
5ŒŽ18“ú�i�…�j 10:10�`11:40�@2A‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº211�j
4�C�Û�Hš‹‰º
- �À’·�F
- “¡–{�@•ÛŽu�i–¼ŒÃ‰®‘åŠwލ•@ˆô�A‰È�j
-
- –xŒû�@—˜”V�i–k—¢‘åŠwˆã—Éq�¶Šw•”ƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Šw‰È�j
�_Œo‹ØŽ¾Š³‚É‚¨‚¯‚é�Û�H�Eš‹‰º�áŠQ‚Ì•a‘ԂƑΉž
- ‰‰ŽÒ�F
- –ì�è�@‰€Žq�i•ºŒÉˆã—ÑåŠwƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“Šw•”�j
�Û�H�Eš‹‰º�áŠQгŽÒ‚ÌƒŠƒnƒrƒŠƒe�[ƒVƒ‡ƒ“�`Œ¾Œê’®ŠoŽm‚Ì—§�ê‚©‚ç�`
- ‰‰ŽÒ�F
- �´�…�@�[Žq�i�é‹ÊŒ§‘��‡ƒŠƒnƒrƒŠƒZƒ“ƒ^�[Œ¾Œê’®Šo‰È�j
�_Œo޾г‚É‚¨‚¯‚éš‹‰º�áŠQгŽÒ‚̃PƒA�\�Û�H�Eš‹‰º�áŠQŠÅŒì”F’èŠÅŒìŽt‚Ì—§�ê‚©‚ç�\
- ‰‰ŽÒ�F
- “¡�X�@‚Ü‚èŽq�i�¹—êŽO•ûŒ´•a‰@ŠÅŒì‘Š’kŽº�j
š‹‰ºŽ¡—Ẫ`�[ƒ€Ž¡—ÂƈãŽt‚Æ‚µ‚Ä‚ÌƒŠƒXƒNŠÇ—�
- ‰‰ŽÒ�F
- ’Óc�@�‹‘¾�i•ŸˆäŒ§�Ï�¶‰ï•a‰@ލ•@ˆô�A‰È�Eèò•”ŠO‰È�j
- ƒe�[ƒ}4�@Lee Silverman Voice Treatment�iLSVT�j�K“¾ƒvƒ�ƒOƒ‰ƒ€
5ŒŽ19“ú�i–Ø�j 9:45�`13:00/14:00�`18:20�@2A‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº211�j
5ŒŽ20“ú�i‹à�j 8:30�`11:50/13:00�`16:30�@2A‰ï�ê�i2�†ŠÙ1ŠK“WŽ¦Žº211�j
ƒy�[ƒWƒgƒbƒv‚Ö↑
’©‚©‚ç”Ó‚Ü‚Å�_Œo“à‰È
- 1�D‚æ‚‚í‚©‚é�Ò�‘MRI‚ÌŒ©•û
5ŒŽ18“ú�i�…�j 8:30�`9:15�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ˆä�ã�@�¹Œ[�iŽD–yŽR‚Ì�ã•a‰@�Ò’Å�E�Ò�‘ƒZƒ“ƒ^�[�j
- ‰‰ŽÒ�F
- ‹TŽR�@—²�iŒ§—§‘½Ž¡Œ©•a‰@�_Œo“à‰È�j
- 2�D‚æ‚‚í‚©‚铪•”MRI‚ÌŒ©•û
5ŒŽ18“ú�i�…�j 9:15�`10:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ŽR˜e�@Œ’�·�i�L“‡‘åŠw”]�_Œo“à‰È�j
- ‰‰ŽÒ�F
- –ö‰º�@�Í�i“s—§�_Œo•a‰@�_Œo•úŽË�ü‰È�j
- 3�D‚æ‚‚í‚©‚éŠjˆãŠw�f’f
5ŒŽ18“ú�i�…�j 10:00�`10:45�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- •ŸŽR�@�G’¼�i‹ž“s‘åŠw”]‹@”\‘��‡Œ¤‹†ƒZƒ“ƒ^�[�j
- ‰‰ŽÒ�F
- ˆÉ“¡�@Œ’Œá�i�‘—§’·Žõˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[”F’m�Ç�æ�iˆã—ÊJ”ƒZƒ“ƒ^�[”]‹@”\‰æ‘œ�f’fŠJ”•”�j
- 4�D‚æ‚‚í‚©‚é�¬Ž™‘ãŽÓ�«Ž¾Š³
5ŒŽ19“ú�i–Ø�j 8:30�`9:15�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- �¼–ì�@ˆêŽO�i�‘—§�¸�_�E�_Œoˆã—ÃŒ¤‹†ƒZƒ“ƒ^�[�_ŒoŒ¤‹†�ŠŽ¾•aŒ¤‹†‘æˆê•”�j
- ‰‰ŽÒ�F
- ‘å–ì�@�k�ô�i’¹Žæ‘åŠw”]�_Œo�¬Ž™‰È�j
- 5�D‚æ‚‚í‚©‚é�¬”]ޏ’²�Ç
5ŒŽ19“ú�i–Ø�j 9:15�`10:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- �¼àV�@�³–L�i�VŠƒ‘åŠw•a‰@”]Œ¤‹†�Š�_Œo“à‰ÈŠw•ª–ì�j
- ‰‰ŽÒ�F
- �Î�ì�@‹Ô–ç�i“Œ‹žˆã‰ÈŽ•‰È‘åŠw�_Œo“à‰È�j
- 6�Dƒ~�[ƒg�EƒU�EƒGƒLƒXƒp�[ƒg
5ŒŽ19“ú�i–Ø�j 10:00�`11:10�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- –ö�@–±�i”F’m�ljîŒìŒ¤‹†�EŒ¤�C‘å•{ƒZƒ“ƒ^�[�j
- ‰‰ŽÒ�F
- Šâ“c�@�½�i“Œ‹ž�—Žqˆã‰È‘åŠw–¼—_‹³Žö�j
-
- ûü‹´�@�º�i–¼ŒÃ‰®‘åŠw–¼—_‹³Žö/“ŒŠC’†‰›•a‰@–¼—_‰@’·�j
- 7�D‚æ‚‚í‚©‚éˆã—Ë@Ší�iBipap�CPEG“™�j
5ŒŽ19“ú�i–Ø�j 11:10�`11:50�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- “’�ó�@—´•F�i�ç—t�_Œo“ï•aˆã—ÃZƒ“ƒ^�[�j
- ‰‰ŽÒ�F
- ’†“‡�@�F�i�‘—§•a‰@‹@�\�VŠƒ•a‰@�_Œo“à‰È�j
- 8�D‚æ‚‚í‚©‚é•s��ˆÓ‰^“®‚ÌŒ©•û
5ŒŽ19“ú�i–Ø�j 13:15�`14:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ‹ß“¡�@’q‘P�i˜a‰ÌŽRŒ§—§ˆã‰È‘åŠw�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ’·’J�ì�@ˆêŽq�i�‘—§•a‰@‹@�\‘Š–ÍŒ´•a‰@�_Œo“à‰È�j
- 9�D‚æ‚‚í‚©‚éƒp�[ƒLƒ“ƒ\ƒjƒYƒ€‚𗈂·Ž¾Š³‚ÌŠÓ•Ê
5ŒŽ19“ú�i–Ø�j 14:00�`14:45�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- –쌳�@�³�O�iˆ¤•Q‘åŠwˆãŠw•”•�‘®•a‰@–ò•¨—Ö@�E�_Œo“à‰È�j
- ‰‰ŽÒ�F
- ŽO—Ö�@‰p�l�i˜a‰ÌŽRŒ§—§ˆã‰È‘åŠw�_Œo“à‰È�j
- 10�D‚æ‚‚í‚©‚鎩—¥�_Œo‹@”\ŒŸ�¸
5ŒŽ19“ú�i–Ø�j 15:00�`16:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ’·’J�ì�@�N”Ž�i–¼ŒÃ‰®‘æ“ñ�Ô�\Žš•a‰@�_Œo“à‰È�j
- ‰‰ŽÒ�F
- š –{�@‰ë–ç�i�Ï�¶‰ï•a‰@�_“Þ�쌧•a‰@�_Œo“à‰È�j
-
- �D–Î�@’q”V�iŠÖ“Œ’†‰›•a‰@�_Œo“à‰È�j
- 11�D‚æ‚‚í‚©‚é�Ò�‘޾г‚ÌŒ©•û
5ŒŽ19“ú�i–Ø�j 16:00�`16:45�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- Š‹Œ´�@–ÎŽ÷�i—鎈ã—ÉȊw‘åŠw•ÛŒ’‰q�¶Šw•”ˆã—ÕŸŽƒŠw‰È�j
- ‰‰ŽÒ�F
- ˆÀ“¡�@“N˜N�iˆÀ�é�X�¶•a‰@�_Œo“à‰È�Cˆã—ÈÀ‘S�j
- 12�D‚æ‚‚í‚©‚é—U”‹Ø“d�}
5ŒŽ20“ú�i‹à�j 8:00�`9:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ›�ŽìŽR�@–«�i–¼ŒÃ‰®‘åŠw•ÛŒ’Šw‰È�j
- ‰‰ŽÒ�F
- �KŒ´�@�L•v�i�_ŒËŽs—§ˆã—ÃZƒ“ƒ^�[’†‰›Žs–¯•a‰@�_Œo“à‰È�j
- 13�D—Õ�°ŽŽŒ±‚É‚¨‚¯‚é“�ŒvŠw“I�l‚¦•û
5ŒŽ20“ú�i‹à�j 9:00�`9:45�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- àV“c�@�G�K�i�‘—§•a‰@‹@�\‰F‘½–ì•a‰@�_Œo“à‰È�j
- ‰‰ŽÒ�F
- �ã�â�@�_”V�i‘å�ã‘åŠw—Õ�°ˆã�HŠw—Z�‡Œ¤‹†‹³ˆçƒZƒ“ƒ^�[�j
- 14�D‚æ‚‚í‚©‚鎡Œ±�EƒRƒz�[ƒgŒ¤‹†
5ŒŽ20“ú�i‹à�j 9:45�`10:30�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- �¼–{�@�¹‘×�i�L“‡‘åŠw”]�_Œo“à‰ÈŠw�j
- ‰‰ŽÒ�F
- ŽR–{�@�°Žq�i�‘—§�zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^�[”]ŒŒŠÇ“à‰È�j
- 15�Dƒ~�[ƒg�EƒU�EƒGƒLƒXƒp�[ƒg
5ŒŽ20“ú�i‹à�j 13:15�`14:15�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ŽR–{�@ú\Žq�i“¡“c•ÛŒ’‰q�¶‘åŠw–¼—_‹³Žö�j
- ‰‰ŽÒ�F
- �…–ì�@”ü–M�i–k—¢‘åŠwˆãŠw•”�_Œo�Ä�¶ˆã—Êw�u�À�j
-
- ŽÄ�è�@�_�i‹ž“s‘åŠw–¼—_‹³Žö�j
- 16�D‚ ‚È‚½‚ÍŒ©—Ž‚Æ‚µ‚Ä‚¢‚Ü‚¹‚ñ‚©�H‚±‚ñ‚È”]�[�Ç
5ŒŽ20“ú�i‹à�j 14:15�`15:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- Ž›ŽR�@–õ•v�iŠâŽèˆã‰È‘åŠw�_Œo“à‰È�E˜V”N‰È•ª–ì�j
- ‰‰ŽÒ�F
- –L“c�@ˆê‘¥�i�‘—§�zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^�[”]ŒŒŠÇ“à‰È�j
- 17�D‚æ‚‚í‚©‚é’†�•�_Œo•a—��i1�j
5ŒŽ20“ú�i‹à�j 15:00�`16:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ‹´‹l�@—Ç•v�i•ŸŽƒ‘º•a‰@�_Œo•a—�Œ¤‹†�Š�j
- ‰‰ŽÒ�F
- �‚‹´�@‹Ï�i�VŠƒ‘åŠw”]Œ¤‹†�Š•a‘Ô�_Œo‰ÈŠw•”–å•a—�Šw�j
-
- Žá—Ñ�@�Fˆê�i�O‘O‘åŠw”]�_Œo•a—�Šw�j
- 18�D‚æ‚‚í‚©‚é’†�•�_Œo•a—��i2�j
5ŒŽ20“ú�i‹à�j 16:00�`17:00�@1D‰ï�ê�i1�†ŠÙ4ŠK‰ï‹cŽº141�{142�j
- �À’·�F
- ‹´‹l�@—Ç•v�i•ŸŽƒ‘º•a‰@�_Œo•a—�Œ¤‹†�Š�j
- ‰‰ŽÒ�F
- ‘ºŽR�@”É—Y�i“Œ‹ž“sŒ’�N’·Žõˆã—ÃZƒ“ƒ^�[�‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒN�j
-
- ‹g“c�@áÁ—��iˆ¤’mˆã‰È‘åŠw‰Á—îˆã‰ÈŠwŒ¤‹†�Š�j